DEVELOPMENT AND APPLICATION OF ADVANCED NMR TECHNIQUES FOR BIOMARKERS IDENTIFICATION by Paris, Debora
UNIVERSITY OF NAPOLI - FEDERICO II
FACULTY OF MATHEMATICAL, PHYSICAL
AND NATURAL SCIENCES
Ph D T H E S I S
to obtain the title of
PhD IN CHEMISTRY
DEVELOPMENT AND APPLICATION OF
ADVANCED NMR TECHNIQUES FOR
BIOMARKERS IDENTIFICATION
Defended by
DEBORA PARIS
NOVEMBER 2006 - DECEMBER 2009
Tutors: Prof. Rosa Lanzetta
"Federio II" University
Napoli, Italy
Dr. Andrea Motta
Institute of Biomoleular Chemistry
(ICB-CNR), Pozzuoli (NA), Italy
Coordinator: Prof. Aldo Vitagliano
"Federio II" University
Napoli, Italy
Contents
Abbreviations iv
Original publiations v
Introdution vii
1 NMR analysis and pattern reognition methods 1
1.1 Introdution . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Pattern reognition methods for biomarker investigations . . . 2
1.3 Multivariate data analysis tehniques . . . . . . . . . . . . . . 3
1.3.1 Unsupervised pattern reognition . . . . . . . . . . . . 4
1.3.2 Supervised pattern reognition . . . . . . . . . . . . . . 7
1.3.3 Multivariate regression . . . . . . . . . . . . . . . . . . 7
1.4 Plots and data visualization . . . . . . . . . . . . . . . . . . . 10
1.5 Appliations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.5.1 a) Human hepatoellular arinoma . . . . . . . . . . . 13
1.5.2 b) Exhaled breath ondensate . . . . . . . . . . . . . . 15
2 CAKE: Monte CArlo peaK volume Estimation 17
2.1 Introdution . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.2 The frational peak method . . . . . . . . . . . . . . . . . . . 19
2.2.1 Peak line shapes in two-dimensional NMR . . . . . . . 19
2.2.2 The R fator estimation . . . . . . . . . . . . . . . . . 23
2.2.3 The Monte Carlo integration . . . . . . . . . . . . . . . 23
3 Fast NMR tehniques in metabonomis 25
3.1 Introdution . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
3.2 Fast multidimensional NMR spetrosopy . . . . . . . . . . . . 26
3.3 SOFAST-HMQC . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.3.1 General aspets . . . . . . . . . . . . . . . . . . . . . . 28
3.3.2 Ernst-angle exitation . . . . . . . . . . . . . . . . . . 29
3.3.3 Proton band-seletive pulses . . . . . . . . . . . . . . . 30
3.3.4 Appliation to protein . . . . . . . . . . . . . . . . . . 32
3.4 Real-time ell
1
H-
15
N metaboli prole . . . . . . . . . . . . . 34
ii Contents
4 NMR metaboli prole experiments 37
4.1 Materials and methods: a) hepatoellular arinoma . . . . . . 37
4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
4.3 Disussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
4.4 Materials and methods: b) exhaled breath ondensate . . . . . 59
4.5 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
4.6 Disussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
5 CAKE simulations and experimental tests 73
5.1 Simulation tests . . . . . . . . . . . . . . . . . . . . . . . . . . 73
5.1.1 Simulations: bias vs. overlapping . . . . . . . . . . . . 73
5.1.2 Simulations: bias vs. eentriiy . . . . . . . . . . . . . 77
5.2 Experimental test . . . . . . . . . . . . . . . . . . . . . . . . . 79
5.2.1 NMR data olletion . . . . . . . . . . . . . . . . . . . 79
5.2.2 Software . . . . . . . . . . . . . . . . . . . . . . . . . . 79
5.2.3 Experimental Results . . . . . . . . . . . . . . . . . . . 80
5.2.4 Bias vs. digital resolution . . . . . . . . . . . . . . . . 81
5.3 Disussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
6
1
H-
15
N SO-FAST-HMQC measurements 85
6.1 Materials and methods . . . . . . . . . . . . . . . . . . . . . . 85
6.1.1 Cell ulturing . . . . . . . . . . . . . . . . . . . . . . . 85
6.1.2 Extrats manipulation . . . . . . . . . . . . . . . . . . 86
6.1.3 Gel eletrophoresis for protein detetion . . . . . . . . 86
6.1.4 NMR experiments . . . . . . . . . . . . . . . . . . . . 87
6.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
6.2.1 T. rotula
1
H and TOCSY spetra . . . . . . . . . . . . 89
6.2.2 T. rotula
1
H-
15
N SOFAST-HMQC spetra . . . . . . . 91
6.2.3 Gel eletrophoresis results . . . . . . . . . . . . . . . . 93
6.3 Disussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
Conlusions 97
Aknowledgements 101
Bibliography 103
Contents iii
iv
Abbreviations
Ala Alanine
APF Alpha-fetoprotein
BMI Body Mass Index
CAKE Monte CArlo peaK volume E stimation
CIR Cirrhosis
COPD Chroni Obstrutive Pulmonary Disease
EBC Exhaled Breath Condensate
FEV Fored Expiratory Volume
FVC Fored Vital Capaity
Gln Glutamine
Glu Glutamate
Gly Glyine
GOLD Global Initiative for Chroni Obstrutive Lung Disease
GPC Glyerophosphoholine
HCC Human Hepatoellular Carinoma
HCV Hepatitis C Virus
HMQC Heteronulear Multiple Quantum Correlation
HS Healthy Subjet
HSQC Heteronulear Single Quantum Correlation
Leu Leuine
MET-CRC Metastasis from ColoRetal Carinoma
MRI Magneti Resonane Imaging
MVA MultiVariate data Analysis
NMR Nulear Magneti Resonane
NOESY Nulear Overhauser Eet SpetrosopY
NT Non Tumoral or Normal Tissue
O2PLS-DA Orthogonal Projetion to Latent Strutures Disriminant Analysis
PBS Phosphate Buer Saline
PC Phosphoholine
PCS Prinipal Components
PCA Prinipal Component Analysis
PCR Priniple Component Regression
PE Phosphoryl-ethanolamine
PLS Projetion to Latent Strutures
PLS-DA Projetion to Latent Strutures Disriminant Analysis
RF Radio Frequeny
SOFAST Seletive Optimized Flip Angle Short Transient
SUS-plot Shared and Unique Struture plot
Thr Threonine
TMAO Trimethylamine-N-oxide
TOCSY TOtal Correlation SpetrosopY
TSP trimethylsilylpropionate
vOriginal publiations
This thesis is based on the following publiations and submitted papers:
1. D. Paris, D. Melk, M. Stohero, O. D'Apolito, R. Calemma, G.
Castello, F. Izzo, G. Palmieri, G. Corso, A. Motta. Monitoring liver
alteration during hepati tumorigenesis by NMR proling and pattern
reognition. Submitted to Metabolomis.
2. G. de Laurentiis, D. Paris, D. Melk, M. Manisalo, S. Marsio, G.
Corso, A. Motta and M. Soa. Metabonomi analysis of exhaled breath
ondensate in adults by Nulear Magneti Resonane spetrosopy. Eur
Respir J 2008; 32: 1-9.
3. R. Romano, D. Paris, F. Aernese, F. Barone, A. Motta, Frational
volume integration in two-dimensional NMR spetra: CAKE, a Monte
Carlo approah. J Magn Res 192 (2008) 294-301.
4. A. Motta, D. Paris, G. Andreotti, D. Melk. Monitoring real-time
metabolism of living ells by fast two-dimensional NMR spetrosopy.
Submitted to Analitial Chemistry.
Introdution
The large amount of data derived from genomis and proteomis, aiming at
eluidating biohemial mehanism, has often revealed the omplexity of el-
lular regulation. Therefore, metaboli studies are inreasingly ontributing to
gene funtion analysis, and an inreased interest in metabolites as biomarkers
for disease progression or response to natural or external intervention is also
growing.
Nulear Magneti Resonane (NMR) spetrosopy has emerged as a key
tool for understanding metaboli proesses in living systems. Reently, a new
approah to eluidate metabolism and its mehanisms has been put forward.
It is metabonomis: an analysis based on a minimum number of assumptions
on the biohemial proesses that our in a living system, mainly investigated
by advaned spetrosopi tehniques inluding mass spetrometry and NMR
spetrosopy.
Metabonomis is formally dened as "the quantitative measurement of the
multi-parametri metaboli response of living systems to pathophysiologial
stimuli or geneti modiation" [1℄. It has been oined to desribe the om-
bined appliation of spetrosopy and multivariate statistial approahes to
investigate of the multiomponent omposition of biouids, ells and tissues.
In partiular, NMR-based metabonomis has proven to be partiularly suited
for the rapid analysis of omplex biologial samples. Indeed, the so generated
NMR spetral results yield a unique metaboli ngerprint for eah omplex
biologial mixture. Aording, if the status of a given organism hanges, suh
as in a disease state or following exposure to a drug, the unique metaboli n-
gerprint or signature reets this hange, thus supplying relevant biohemial
indiations.
Multivariate statistial methods provide an expert means of analyzing and
maximizing information reovery from omplex NMR spetral data. Detailed
inspetion of NMR spetra and integration of individual peaks an give valu-
able information on dominant biohemial hanges. However, subtle variation
in spetra may be overlooked and it is diult to envisage general eets as
a funtion of both dose and time in a large ohort of samples with biologi-
al variability. Pattern reognition methods an be used to map the NMR
spetra into a lower dimensional spae (than that implied by the number of
points in the digital representation of the NMR spetrum) suh that any lus-
tering of the samples based on similarities of biohemial proles an easily
be determined and the biohemial basis eluidated.
The development of new spetrosopi tools for high thoughput analysis of
seleted biohemial pathways is ruial for metabolome investigations. The
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purpose of the present thesis is to explore the reent NMR improvements by
applying and developing new metabolomi strategies for biomarkers disovery,
inluding NMR data handling, peaks quantiation and fast data aquisition.
In the rst hapter, a general overview of the multivariate data analysis
and pattern reognition methods is given. In partiular, we highlighted the
advantages of using those tools to NMR data for biomarkers investigations.
The most ommon regression methods (Prinipal Components Analysis and
Projetion to Latent Strutures) and plot visualization (satters sores plots
and loadings plots) are desribed to supply the reader with the basi statis-
tial tools for a better understanding of the appliation the biologial issues
reported in the last setion. NMR and regression tehniques were applied
to dierent patient lasses to disriminate a) hepati tissues and b) exhaled
breath ondensates belonging to patients with dierent pathologial states.
In the seond hapter we desribe a new integration method developed for
two-dimensional NMR spetra quantiation. Indeed, one-dimensional NMR
spetra are often too omplex for interpretation and metabolite identiation
as most of the signals overlap heavily. By introduing an additional dimen-
sion, peaks are spread and spetra are simplied. Quantitative information
from multidimensional NMR experiments an be obtained by peak volume
integration. The standard proedure (seletion of a region around the hosen
peak and addition of all values) is often biased by poor peak denition beause
of peak overlap. In this hapter we reported a simple method, alled CAKE,
for volume integration of moderately to strongly overlapping peaks. Start-
ing from the peak line shapes in two-dimensional NMR, we desribe how the
CAKE routine was onstruted using the Monte Carlo Hit-or-Miss tehniques
and some simple mathematial relationships.
The third hapter is a general introdution to fast NMR two-dimensional
spetrosopy. In partiular, we desribe the details of the so-alled SO-FAST-
HMQC pulse sequene [2, 3℄ we would like to apply to investigate in ell
metabolism. The SOFAST-HMQC sequene was reated and designed by
Shanda and Brutsher and o-workers for proteins as it is based upon very
short experimental reyle delays, whih, of ourse, must rely on short T1
relaxations time. At a rst sight, this is an evident drawbak sine metabolites
are often haraterized by T1 relaxations time longer than those of proteins.
However, as detailed in Chapter 6, we have applied the SO-FAST experiment
to the diatom T. rotula ells obtaining, to the best of our knowledge, the rst
appliation of fast NMR spetrosopy to
1
H-
15
N metaboli proling diretly
on living ells.
The fourth hapter reports the metaboli haraterization of: a) the pro-
gressive liver alterations during tumorigenesis and b) the exhaled breath on-
densate of patients with airway diseases. We desribe the multivariate data
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analysis and pattern reognition methods starting from NMR spetra of liver
tissues extrats and exhaled breath ondensates. a) Samples were olleted
and grouped in four lasses: hepatoellular arinoma (HCC) developed on
hepatitis C irrhosis (CIR), the irrhoti adjaent HCC tissue, liver metasta-
sis from oloretal arinoma (MET-CRC), and the related adjaent "normal"
tissue onsidered as ontrol. The results indiate that the latate/gluose ratio
is able to haraterize and distinguish the analyzed subsets of hepati samples.
In partiular, we identied a statistial model that ould be used to distinguish
hepati metastasis and human hepatoarinoma from a "normal" (healthy)
hepati tissue. b) Exhaled breath ondensates (EBC) and paired salivas were
olleted from healthy subjets, laryngetomized and hroni obstrutive pul-
monary disease (COPD) patients. The results showed that all NMR saliva
spetra were signiantly dierent from orresponding EBC samples, whih
assessed no saliva ontamination in EBC samples. Indeed, EBC taken from
ondensers washed with reommended proedures invariably showed spetra
perturbed by disinfetant. By arefully hoosing non-ontaminated spetra
regions, eah EBC sample lustered with orresponding samples of the same
group, while presenting intergroup qualitative and quantitative signal dier-
enes.
The fth hapter is dediated to the simulations and the experimental tests
of the CAKE integration method. In partiular, we tested CAKE integration
eay on simulated peaks in dierent overlapping onditions and signal-to-
nose ratios. Furthermore, sine experimental two-dimensional peak shapes
are lose to ellipti, we tested CAKE on a simulated ellipse of known volume
at dierent eentriity degrees. Finally, we used CAKE on experimental
NMR data by making use of a sample ontaining two tripeptides at known
onentrations. Peak volume estimations obtained with CAKE omparison
with standard methods indiated that CAKE obtains un umbiased volume
estimation.
In the sixth hapter, the appliation of the SO-FAST-HMQC experiment
to
15
N-labeled Thalassiosira rotula diatoms is desribed. We demonstrate the
eetive appliability of SO-FAST experiments to ells, olleting spetra in
10-15 s of aquisition time. Our results, denitively show the appliability of
SO-FAST experiments for fast metaboli data aquisition thus providing an
instantaneous of the metaboli pathways going on in a well-dened physiolog-
ial state, therefore avoiding the measurement of an "average" metabolism,
obtainable with aquisition time of hours.
Chapter 1
NMR analysis and pattern
reognition methods
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1.1 Introdution
Metabonomis and metabolomis based on Nulear Magneti Resonane
(NMR) spetrosopy are nowadays widely used for toxiologial assessment,
biomarker disovery, and studies on toxi mehanisms. The metabonomi
approah, (dened as the quantitative measurement of the multiparametri
metaboli response of living systems to pathophysiologial stimuli or geneti
modiation) was originally developed to assist interpretation in NMR-based
toxiologial studies. However, in reent years there has been a onvergene
with metabolomis and other metaboli proling approahes developed in
plant biology, with muh wider overage of the biomedial and environmental
elds. Speially, metabonomis involves the ombination of spetrosopi
tehniques with statistial and mathematial tools to eluidate dominant pat-
terns and trends diretly orrelated with time-related metaboli utuations
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within spetral data sets, usually derived from biouids or tissue samples.
Temporal multivariate metaboli signatures an be used to disover biomark-
ers of toxi eet, as general toxiity sreening aids, or to provide novel meh-
anisti information. This approah is omplementary to proteomis and ge-
nomis and is appliable to a wide range of problems, inluding disease diag-
nosis, evaluation of xenobioti toxiity, funtional genomis, and nutritional
studies. The use of biologial uids as a soure of whole organism metaboli
information enhanes the use of this approah in minimally invasive longitu-
dinal studies.
In this hapter, the main features of the statistial tools for suh inves-
tigation are exposed. As desribed in Chapter 4, we applied the "pattern
reognition analysis" to metabonomi haraterization of: a) liver alterations
during hepati tumorigenesis and b) exhaled breath ondensates (EBC) from
patiens with airway diseases. Tissue samples assoiated with four dierent
liver pathologial states olleted from surgial exisions and EBC obtained
by ooling exhaled air from spontaneous breathing, were analyzed by
1
H NMR
spetrosopy oupled with multivariate data analysis (MVA). Metaboli pro-
les were analyzed and lustering analysis readily separated and lassied the
tissues and the exhaled breath ondensates aording to the relative patho-
logial onditions.
1.2 Pattern reognition methods for biomarker
investigations
The use of hemometri methods to analyze omplex spetral data sets
was perhaps the most important development in the pratial appliation of
metabonomis, and has dened the development and progression of the eld
ever sine. Early pattern reognition studies on NMR data employed a re-
dutionist approah preseleting the metabolite signals of interest. However,
NMR spetra yield a unique metaboli ngerprint for eah biouid, sample
whih onsists of thousands overlapping resonanes, is obviously of limited
use. If the status of a given organism hanges, suh as in a diseased state or
following exposure to a drug, the unique metaboli ngerprint or signature
reets this hange [1, 4℄.
Multivariate statistial methods provide a robust tool for analyzing and
maximizing information reovery from omplex NMR data sets. Detailed in-
spetion of NMR spetra and integration of individual peaks an give valuable
information on dominant biohemial hanges; however, subtle spetral vari-
ation may be overlooked, and it is diult to envisage general eets as a
funtion of both dose and time in a large ohort of samples with biologial
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variability. Pattern reognition methods an be used to map the NMR spetra
into a representative lower dimensional spae suh that any lustering of the
samples based on similarities of biohemial proles an be determined and
the biohemial basis of the pattern eluidated.
As desribed in the next setion, the rst step in metabonomis is spetra
lassiation aording to peak patterns. The seond one relies upon iden-
tiation of spetral features responsible for the lassiation (aording to
physiologial or pathologial status), and this an be ahieved via both super-
vised and unsupervised pattern reognition tehniques.
1.3 Multivariate data analysis tehniques
MVA eiently extrats useful information from data generated via hemial
or physial measurements. Indeed, most sienti data generating systems are
multivariate, i.e. any partiular phenomenon we would like to study in detail
usually depends on several fators (variables). For instane, the health status
of a human individual depends on many elements, inluding genes, soial sta-
tus, eating habits, stress, environment et. Consequently, it is often neessary
to simultaneously sample several variables to fully desribe the system.
A panoply of multivariate data analysis tehniques exists, and the hoie
depends on the answer one wants to obtain. A large part of the method is
onerned with simply "looking" at the data, haraterizing then by useful
summaries and displaying the intrinsi data strutures visually by suitable
plots. Therefore, it is important to formulate the analytial problem in suh
a way that the goal is lear and the data are in a form suited for reahing
this goal. Usually, spetral data are preproessed, whih typially involves
Fourier transformation, alibration of the hemial shift sale with respet to
an internal referene standard, and phase and baseline orreted. For multi-
variate modeling, NMR spetra are often divided into vertial regions (along
the hemial shift axis), and their areas summed to provide an integral so that
the intensities of peaks in suh dened spetral regions an be extrated; suh
a proess is known as buketing. As a onsequene, a data matrix is obtained,
whih onsists of rows that represent observations/samples, and olumns that
represent variables as the spetral. From this matrix format, data are suit-
able for MVA that an be used for a number of distint, dierent purpose:
data desription (explorative data struture modeling), disrimination and
lassiation, regression and predition. So, more simply, we an desribe
MVA as omposed by two main methods: multivariate lassiation (pattern
reognition) and multivariate regression tehniques [5, 6, 7, 8℄.
The pattern-reognition tehniques deal with the separation of data
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groups. Suh lustering ability, even for large set of measurements, gives
the possibility to derive a quantitative data model in order to disriminate
among dierent groups of data. Multivariate lassiation an be divided
into two ategories: unsupervised and supervised proedures. In an unsuper-
vised pattern reognition, no a priori knowledge of the training set samples is
required, i.e. the lass membership of the training samples. Hene, samples
will be grouped into a number of lasses with ertain ommunalities without
initial qualiation of the samples and their lass assignment. Therefore, a
possible struture within ertain data sets may be reognized even without
the initial knowledge of the number of lasses and the expeted dierenes. In
ontrast, a supervised pattern reognition requires a priori knowledge about
the lasses ontained within the training samples, i.e. whih sample belongs
to whih lass, suh as, samples from disease and from healthy patients. Con-
sequently, unsupervised pattern-reognition tehniques are exploratory meth-
ods for data analysis, seeking inherent similarities in the data, and grouping
them in a "natural" way. This approah allows unexpeted grouping within
a training set may be disovered often not initially evident, as for a group
of disease-related samples that might additionally separate into two or more
distintly dierent lasses.
Supervised pattern-reognition tehniques are dierent, as they group data
into predened lasses during the training proedures, thereby allowing a more
preise lassiation within the lass boundaries. Clearly, eah approah has
strengths and weaknesses rendering a general reommendation impossible.
Eorts have been made to ombine dierent pattern-reognition methods for
improved lassiation results [9, 10℄. In general, suient auray and ro-
bustness of lassiation and preditive regression models has to be evaluated
with an appropriate set of validation samples prior to the analysis of un-
knowns.
1.3.1 Unsupervised pattern reognition
Prinipal Component Analysis (PCA)
PCA onstitutes the most basi "work horse" of all of multivariate data anal-
ysis. The starting point is an X-matrix with n objets and p variables (an n
by p matrix) (Figure 1.1), often alled the "data matrix" or the "data-set".
The objets an be the observations, samples or experiments, while the vari-
ables typially are "measurements" of eah objet. In our ase, the n objets
are NMR spetra of samples, while the p variables are integrations of spetra
setions, alled "bukets", of a well dened size.
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Figure 1.1: X matrix or data matrix onsisting of n observations (n NMR spetra) and
p variables (p spetral regions "bukts").
The purpose of PCA, so as of all MVA tehniques, is to deompose the data
in order to detet and model the "hidden phenomena" for whih the onept
of variane is very important. In fat, the fundamental assumption for this
method is that the underlying diretions with maximum variane are more
or less diretly related to the hidden phenomena. The data matrix X, with
its p bukets olumns and n spetra rows, an be represented in a Cartesian
(orthogonal) oordinate system of dimension p alled the "variable spae" or,
in this ase, the "spetrosopi spae", meaning the spae spanned by the p
variables orresponding to the bukets. The dimension of this spae is p, but
the dimension related to the rank of the matrix representation (mathemati-
ally: the number of independent basis vetors; statistially: the number of
independent soures of variation within the data matrix) may be often less
than p. PCA seeks this operative or eetive dimensionality by a linear oor-
dinate transformation from the variable spae into a spae whih is spanned
by a lower number of new oordinates, alled "prinipal omponents" (PCS),
whih, in turn are related to diretions of largest varianes in the ensemble
(Figure 1.2). The rst prinipal omponent (PC1) explains most of the vari-
ane, the seond (PC2) the seond most, et. Therefore, PCA is a powerful
data-redution tehnique that an ondense original data (with a large num-
ber of initial variables) to a dataset with only few variables reeting the most
relevant analytial information.
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Figure 1.2: Representation of all observations in the data matrix in a 3D spae where the
omputed prinipal omponents are shown as vetor arrows.
By looking into two-dimensional subspaes like PC1 vs. PC2, one ould see
if all spetra have similar positions (sores) with respet to the orresponding
part of the variane (Figure 1.3). The orresponding plots are alled "sores
plots".
Figure 1.3: Representation of all observations from the variable spae to the prinipal
omponents spae. Suh PC system onsists of a number of PCS , eah lying along a
maximum variane diretions in dereasing order. Sores plot are obtained as projetion of
observations onto the PCS axes.
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A further step is to look for further strutures in the ensemble by reduing the
variane spae suh that most of the total variane (like 99.5%) is explained
and the rest is regarded as noise. The redued spae is alled "model spae".
By alulating quantities like distane to model of eah spetrum it is possible
to hek if all spetra are still similar or if some spetra appear outside this
model spae. This is also the basis for lassiation. The relation between
the variables in the new prinipal omponent spae and original spetrosopi
spae are desribed by the so-alled loadings (ref. Setion 1.4). By studying
one or two-dimensional loadings plots it is possible to understand how buk-
ets ontributed to the onstrution of the new prinipal omponent spae. A
high loading of a buket (variable) indiates that the orresponding area (or
peak) in the spetrum was important. The loadings plots provide the link
between statistial and spetrosopi interpretation of the phenomena in the
ensemble. This is essential beause PCA itself reveals statistial phenomena
but does not explain the reason for these phenomena, for example in hemial
terms. This interpretation remains to be done after the PCS alulation.
1.3.2 Supervised pattern reognition
Projetion to Latent Strutures Disriminant Analysis (PLS-DA)
PLS-DA is a disriminant method derived from PLS regression models [11℄
(see next Setion). Here, the threshold for separating two lasses is alulated
using the observed distribution (P1, P2...Pm; m = number of lasses; Pm =
probability that the spetra belongs to lass m) of the predited values, and
the Bayesian theorem, whih alulates the probability of one objet belonging
to a ertain lass by use of the ratio
Pi∑
Pm
, for disriminating dierent lasses.
Barker et al. desribe how PLS-DA statistially onnets with disriminant
analysis, and may thereby serve as a disriminant tool [11℄. For lassiation,
PLS is guided by among-group variane, while PCA, whih is guided only by
the total variane, annot disriminate among-group from within group vari-
ane. Compared to PCA, it is lear that PLS-DA provides favorable disrim-
ination, espeially if the within-group dierene dominates over among-group
dierene. In reent studies, this model was suessfully used to disriminate
artherosleroti and normal aorta tissues in rabbit models [29, 48℄.
1.3.3 Multivariate regression
Priniple omponent regression (PCR)
During PCR, PCA is used to ompress and deompose the original spetra
generated from training samples into fewer variables (PCS) apturing the rel-
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evant varianes within the data set, and then using the sores derived from
the training data to reate a quantitative model. During the predition of un-
knowns, the sore vetors of the unknown are derived based on their unique
spetra, and regressed against the PC vetors obtained from the alibration
samples for retrieving a quantitative predition of the unknown onentration.
PCR was also suessfully implemented as a lassiation tool by Haaland et
al., and was used to lassify ell and tissue samples [12℄.
Projetion to Latent Strutures (PLS) regression
PLS also starts out with an ensemble of spetra, whih is translated into the X
matrix, ommonly alled the "buket table" where the number of p variables
is the number of bukets. However, a seond information table is needed.
It ould omprise other spetrosopi data or any other sort of data, like
onentration measurements, arbitrary id numbers, disease haraterizations
et. This seondary table is ommonly alled Y matrix or Y table (Figure
1.4).
Figure 1.4: X matrix ontaining data and observations, and Y matrix ontaining, for eah
observation, data related to sample information like onentrations or disease lassiations.
The number of Y variables (also alled response variables or q variables) is
idential to the number of olumns in the Y table. Unlike PCA, whih detets
the diretion of maximum variane in the X matrix, PLS tries to nd the best
orrelation between the X and Y matries using relevant linear ombinations
of variables in the X and Y tables. It detets that part of the variane in the
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X table whih ts best the data in the Y table in an iterative way. While
in PCA the user has to deide the number of prinipal omponents he wants
to work with (typially suh that most of the variane in the ensemble is
explained), in PLS he has to dene the number of PLS omponents (fators)
that should be used to model the Y table. This number is often not obvious.
In priniple, it should be hosen suh that the non-explained varianes in X
and Y spae approah a minimum, and suh that the PLS model has good
preditive apabilities. Unlike the number of prinipal omponents in PCA,
the number of PLS fators must be arefully hosen. The results of a PLS
alulation are presented in similar ways ompared to PCA (again, we get
sores and loadings plots of the X table data). However, there are a number of
further plots whih need interpretation, e.g. showing the orrelation between
X and Y tables or the predition power of the model. Similarly to PCA, the
model building proess in PLS is to nd the orret statistial variables (e.g.
number of PLS fators), and the right spetra that should stay in the model.
One the model is established (alibrated) it is used to analyze new spetra
with missing Y table information and use the onstruted model to predit it.
This is extremely valuable if the Y table would have been expensive to obtain
otherwise, or if it an not be experimentally obtained at all.
There is a seond interesting usage of PLS motivated by the following
situation. Ensembles often ontain dierent groups of spetra, say nor-
mal/abnormal or originate from dierent samples, say kidney/liver et. One
then would like to see these groups in a PCA analysis, e.g. as dierent lus-
ters in a sores plot. However, PCA is designed to nd the maximum variane
in the ensemble but not neessarily that part of the variane that results in
the best disrimination. To enfore this, it is of ourse possible to perform
a spetrosopi analysis rst and nd signals responsible for disrimination,
and then use these signals in a subsequent PCA. Alternatively, it is possible
to supply a Y table whih ontains disriminating information (in the most
simple ase just 0 and 1). A PLS then detets that part of the variane in
the ensemble, whih ts best to the Y table. A sores plot of the ensemble
data may possibly show a good disrimination. How safe is suh a proeed-
ing, it depends on the appliation. With two indistinguishable groups in the
ensemble, a PLS using a Y table with 0 and 1 will not provide a good dis-
rimination and the orrelation plots between X and Y data would indiate
poor orrelation. If the ensemble in fat ontains two groups of spetra, PLS
with a orresponding Y table an indeed improve disrimination. This should
however be onrmed by spetrosopi or other data, otherwise a not solid
disrimination ould be overemphasized.
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Orthogonal Projetion to Latent Strutures Disriminant Analysis
(O2PLS-DA)
O2PLS is a multivariate regression method that extrats linear relationships
from two data bloks, X and Y, by removing the strutured noise [13, 14℄. In
partiular, O2PLS deomposes the systemati variation in the X-blok into
two model parts: the so alled preditive part, whih models the orrela-
tions between X and Y, and another alled the orthogonal part, whih is not
related to Y. Like other PLS regression tehniques, O2PLS an be used to
perform disriminant analysis by introduing suitable dummy variables. The
main advantage in using O2PLS-DA tehnique is the redution of the model
omplexity. For m lasses, the dimension of the preditive spae is m-1, and
the lassiation model an be investigated by using only m-1 latent ompo-
nents. Useful visualization tool, as the orrelation plot or S-plots, an be used
to highlight the role of the X-variables in the lassiation model.
1.4 Plots and data visualization
As stated in the previous Setions, multivariate methods allow investigation of
the relationships between all variables in a single ontext. These relationships
an be displayed in plots like time series, histograms and pair-wise satter
plots.
Model overview plots
Model overview plot ould be presented as an histogram showing how the
umulative explained variane (R2 value) gets larger as the number of the PCS
inreases on horizontal axis ( Figure 1.5). The number of PCS for the model
should be suh that R2 (sum of squares of all the X matrix variables explained
by the extrated omponents) and Q2 (the umulative ross validated R2)
values are somewhere in the at asymptoti part of urve histogram.
Inuene plots
Inuene plot shows spetra in a diagram where the vertial axis is a measure
of how far a spetrum is from the model spae (o model distane). If a
spetrum is in the upper part of this display it is most likely outside the
model spae. The horizontal axis is a measure how far a spetrum is from the
model enter, after being projeted into the model spae (in model spae). If
a spetrum appears on the right side, it has a strong inuene on the model.
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The two lines displayed inside the plot are so-alled 95% ondene limits.
Spetra inside these limit belong to the model with a probability of 95%.
Sores plots
Two dimensional sores plots of the form PCi vs. PCj (e.g. PC1 vs. PC2)
show how the spetra are distributed in the orresponding sub-spae (Figure
1.6). This plot is used to see whether spetra are gathered in groups or are
outlying from others. Dominant eets in the PCA may typially be seen
in plots that involve the rst few PCS. Sometimes eets in higher PCS
are equally important; so with PC1, PC2 and PC3 a 3D sores plot an be
visualized. It ould, for example, indiate strong unexpeted signals in a
spetrum but present in only very few spetra. By heking the inuene plot
or all sores plots it an be seen whether higher PC sores plots should be
onsidered.
Loadings plots
Loading plot shows how PCS are related to the original bukets. The 1D
loadings plot of a prinipal omponent looks like a spetrum. Peaks indiate
those bukets (and therefore spetral regions) whih ontributed signiantly
to that prinipal omponent. 1D loadings plots, e.g. of PC1 show how the
original variables (bukets) ontributed to the onstrution of a PC. They look
like a 1D spetrum and the largest peaks indiate the strongest ontributions.
2D loadings plots (Figure 1.7), e.g. of PC1 and PC2 relate loadings of the
dierent PCS to eah other. Eah point in suh a plot orresponds to a pair
of bukets. A ombined interpretation of sores and orresponding loadings
plots an for example show the bukets responsible for an outlying behavior.
Combined interpretation means to look for spetra whih are outlying along a
ertain diretion, and for loadings whih are lined up along the same diretion.
For example, if a spetrum is outlying in a partiular position in the plot, the
loadings points into the same diretion indiate the resonanes responsable
for spetrum outlying.
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Figure 1.5: Model overview plot: R2 and Q2 values are parameters desribing how the
new PCS omponents t the PCA model.
Figure 1.6: PCA satter plot PC1 vs. PC2 of two representative lass samples.
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Figure 1.7: Sores satter plot reporting the bukets responsible for the samples distri-
bution of PCA in Figure 1.6.
1.5 Appliations
1.5.1 a) Human hepatoellular arinoma
The human hepatoellular arinoma (HCC) is one of the most ommon ma-
lignanies whose inidene is steadily inreasing worldwide [15, 16℄ (Figure
1.8). The liver is also the most frequent site of metastati olonization, and
hepati metastasis are far more ommon than primary liver aners in West-
ern ountries [17℄. Beause of its aggressiveness, early detetion of HCC is
ruial to shedule more eetive therapeuti options and improve patients'
survival. The most ommonly enountered dierential diagnosis in liver is
HCC versus intrahepati holangioarinoma or metastati adenoarinoma.
Moreover, small hepati lesions (≤ 1.5 m in diameter) are frequently di-
ult to haraterize, and diagnosti inauray may lead to inorret patient
treatment. Magneti Resonane Imaging (MRI) has been shown to eetively
dierentiate benign and malignant small hepati lesions with moderate to
good interobserver agreement [18, 19℄. Yet, the linial importane of these
lesions often remains unknown until biopsy or follow-up imaging is performed
months later [20℄. Serologial markers (suh as alpha fetoprotein) an be use-
ful in narrowing the dierential diagnosis when they are markedly elevated
but a substantial number of patients unfortunately do not have high levels
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of these markers at the time of presentation. Therefore, a tissue diagnosis is
often required, beause the presene of hepati metastasis may substantially
alter prognosis and therapy [21℄.
Figure 1.8: Annual age-adjusted inidene rates per 100,000 and trends, all hepatoellular
arinoma ases and by sex, 1975 to 2005 (Surveillane, Epidemiology, and End Results 9
[SEER9℄).
Histopathologial evaluation of biopsy samples plays a key role in ahiev-
ing an aurate diagnosis, and ne needle aspiration biopsy of liver has gained
inreasing aeptane as the diagnosti proedure of hoie, and is reported
to be safe, minimally invasive, aurate and ost eetive [20℄. A possible
disadvantage of the biopsy-based histopathology is represented by the dif-
ulties in its use as a sreening approah for early tumor detetion. On
the other hand, MRI and all the ommonly-used imaging tehniques, whih
are widely aepted as sreening tests, provide limited biohemial informa-
tion (i.e., metabolite omposition), whih may be useful to disriminate the
dierent hepati lesions at the moleular level. Evaluation of intraellular
metaboli proles of hepatitis C virus (HCV) infeted liver, HCC and metas-
tases is laking and NMR spetrosopy proles ould ontribute to larify
these aspets. NMR is an established analytial tool extensively used for
probing the metaboli status of biologial samples [22, 23, 1℄, and provides
a "metaboli ngerprint" useful to investigate physiopathologial states. As
pointed out in the previous setions, the presene of disriminating elements
in an NMR spetrum or in spetra belonging to the same lass an be tested
with multivariate data analysis, whih allows a thorough omparison of sets
of spetra [24℄. As shown in this hapter, some of the most often used teh-
niques to identify models for possible groups as well as to predit a probable
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lass membership for new observations are based on PCA or multivariate re-
gression methods as O2PLS to perform disriminant analysis [25℄. As it will
be desribed in the Chapter 4, we used multivariate data analysis to gain
insight into hidden phenomena and trends in ensembles of dierent hepati
tissue spetra whih would not be obvious in the usual spetrosopi view.
Suh an analysis will also point out the most relevant NMR signals for the
lassiation of tissue spetra, learly indiating hanges in onentration of
a spei metabolite as well as its relative variation.
In-vitro studies onduted on tissue extrats have shown that high-
resolution NMR improves both spetral resolution and sensitivity, yielding
more detailed metabolite information [13, 14℄. On the ontrary, in-vivo NMR
an detet non-invasively biohemial hanges in human aners [26℄, liver dis-
eases suh as hroni hepatitis [27℄, irrhosis and arinoma [28, 29℄. However,
spetral resolution and sensitivity makes in-vivo NMR of limited value for
the identiation and quantiation of metabolites [30℄. A useful diagnosti
strategy ould be represented by a ombination of in-vitro and in-vivo NMR
ompared to histologial analysis in order to follow-up variations of distin-
tive lesions lassied by high-resolution NMR spetra. We here followed the
biohemial progression of human hepati lesions through NMR-based analy-
sis of primary (HCC) and seondary (metastases from oloretal arinoma)
liver tumors, irrhoti tissues, and non-irrhoti normal liver tissues adjaent
metastases, ahieving a metaboli dierentiation of the various pathologial
onditions based upon the variation of the intraellular latate/gluose ratio,
thus suggesting that suh a signal pattern may at as a potential marker for
assessing pathologial hepati lesions.
1.5.2 b) Exhaled breath ondensate
Exhaled breath ondensate (EBC) is a simple, noninvasive and useful tool
to study the biohemial and inammatory moleules in the airway lining
uid [31℄. Obtained by ooling exhaled air from spontaneous breathing, EBC
predominantly ontains water vapour and ollets volatile and nonvolatile
substanes from the lower airways [32℄. As suh, it an also be onsidered a
matrix for analysis of environmental toxiants and for evaluation of exposure
monitoring [33℄. Very few data are available on EBC metabolite omposition;
often single inammatory moleules are analysed by ELISA and spetrosopi
methods.
Sine NMR, oupled with pattern reognition methods, has been proved to
be a powerful tool for biouids to probe the metaboli status [34, 1, 23, 35℄ and
to investigate dierent diseases [36, 37, 38, 39℄, we applied it to haraterize
EBC metaboli prole.
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Reently, EBC of asthmati hildren has been investigated by NMR and
statistial analysis [40℄. To date, there are several reommendations on the
methodologial approah to EBC olletion, but its standardization is not
ompletely dened, as most inammatory mediators, obtained through tra-
heostomies, are similar to those olleted in the mouth [41, 42℄.
The aims of the present study were:
1. To validate the NMR metabonomi approah to analysis of EBC in
adults, assessing the role of pre-analytial variables (saliva and disin-
fetant ontamination) potentially inuening EBC and evaluating the
stability and reproduibility of samples;
2. To evaluate the possibility of disriminating healthy subjets from pa-
tients with airway disease.
As detailed in Chapter 4, in total, 36 paired EBC and saliva samples, ob-
tained from healthy subjets, laryngetomized patients and hroni obstru-
tive pulmonary disease (COPD) patients, were analyzed by means of
1
H-NMR
spetrosopy followed by prinipal omponent analysis. The eet on EBC of
disinfetant, used for reusable parts of the ondenser, was assessed after dif-
ferent washing proedures. To evaluate intra-day repeatability, eight subjets
were asked to ollet EBC and saliva twie within the same day. All NMR
saliva spetra were signiantly dierent from orresponding EBC samples.
EBC taken from ondensers washed with reommended proedures invariably
showed spetra perturbed by disinfetant. Eah EBC sample lustered with
orresponding samples of the same group, while presenting intergroup qual-
itative and quantitative signal dierenes (94% of the total variane within
the data). In onlusion, the nulear magneti resonane metabonomi ap-
proah ould identify the metaboli ngerprint of exhaled breath ondensate
in dierent linial sets of data. Moreover, metabonomis of exhaled breath
ondensate in adults an disriminate potential perturbations indued by pre-
analytial variables.
Chapter 2
CAKE: Monte CArlo peaK
volume Estimation
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This hapter is based on the paper: R. Romano, D. Paris, F. Aernese,
F. Barone, A. Motta. Frational volume integration in two-dimensional NMR
spetra: CAKE, a Monte Carlo approah. J Magn Res 192 (2008) 294-301.
2.1 Introdution
NMR spetra an provide quantitative analysis of a sample, and a standard
1D
1
H-NMR spetrum is often used to obtain a reliable evaluation of peaks.
However, as the omplexity of the sample inreases, resonane overlap beomes
a serious problem that easily degrades the auray of the analysis, and 2D
NMR data are required to gain suient disrimination of resonanes. Quan-
tiation of NMR spetra is also fundamental in the new emergering eld
of metabolomis/metabonomis [43, 34℄, and in the struture and dynamis
of proteins in solution [44℄. This widespread requirement of deriving quanti-
tative information from NMR data has prompted the need to nd methods
for aurate and preise integration proedures both for 1D and 2D spetra.
This paper desribes a new simple method for peak volume integration in
2D spetra, whih appears to be partiularly suited for overlapping peaks.
Quantitative information in NMR spetra is brought by peak areas [45℄. Two
methods of peak integration are often used: diret summation of spetral
data points and peak parameter searh by urve tting. In the absene of a
model for the peak shape, diret summation appears to be the only pratial
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tehnique. It is not, however, adaptable to (partially) overlapping peaks, and
introdues two kinds of systemati errors. One is due to the approximation
aused by the assimilation of the integral of a ontinuous funtion with a -
nite sum [46℄; the seond one is aused by the parts of the peaks that are left
outside of the integration range [47℄.
Ideally, an eient integration method should be appliable even when in
the presene of peak overlap or artifats. Many of the available NMR proess-
ing and analysis pakages ahieve volume integration by diret summation of
all data points within a polygonal bounding the peak. This proedure requires
a reliable denition of the peak area: the irling should be as large as pos-
sible to enable for a omplete integration, but also small enough to minimize
inlusion of artifats (baseplane rolls, t1 noise, tails of other peaks). As suh,
the idealized proedure appears to be restrited to well-resolved peaks. In au-
tomated protools, a possible way to dene the area integration makes use of
the observation that the slope of a peak height dereases monotonially with
the distane to the peak enter, at whih point it approximates zero [48, 49℄.
A similar approah denes the peak integration area using an iterative region-
growing algorithm [50, 51, 52℄, whih reognizes all data points that are part
of a given peak, and the integration is performed on a user-dened threshold
level. This proedure works quite satisfatorily even for overlapping peaks, as
long as the peak maxima are visibly resolved and therefore reognizable by
the peak-piking proedure. In a dierent approah, the peaks are tted by
a set of referene peaks dened by the user [53, 54, 55℄. In order to obtain
aurate line shapes and integrals in one dimension, it is neessary to apply a
nonlinear urve-tting proedure [56, 45℄. Although this protool is probably
best suited in ases where peaks strongly overlap, it hinges on the areful
denition of suitable referene peaks and seletion of initial tting parameters
by the user.
A general approah for peak integration would be to exploit the peak sym-
metry as a riterion to evaluate the peak volume. Symmetry onsiderations
have previously been used for pattern reognition in 2D NMR spetrosopy
[57℄, and only rarely for the analysis of in-phase peaks as in NOESY and
TOCSY experiments. The program AUTOPSY used symmetry for automated
peak piking in multi-dimensional NMR spetra of proteins [58℄. Here we pro-
pose CAKE, a novel integration method based on peak symmetry. After a
2D Lorentz-Gauss time domain ltering, the spetral lines are onverted into
Gaussian lines, therefore presenting a ylindrial or elliptial symmetry. By
assuming the vertial axial symmetry of individual peaks (a peak with a unique
enter orresponds to its maximum), the volume is obtained by multiplying
a seleted volume fration by a fator R, whih represents a proportionality
ratio between the total and the frational volume, optimized by Monte Carlo
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tehniques. This minimalisti approah warrants that the frational volume
an be hosen so as to minimize the eet of overlap in omplex NMR spetra.
When applied to simulated and experimental 2D in-phase peaks with dierent
degrees of overlap, CAKE (Monte CArlo peaK volume E stimation) obtains
an unbiased volume estimation. It is shown that, ompared with the diret
summation proedure, the frational volume approah yields rather good es-
timates of the peak volumes, even for signiant overlap, as long as a single
ontour level and its enter arising from a single peak an be deteted.
2.2 The frational peak method
2.2.1 Peak line shapes in two-dimensional NMR
In high-resolution NMR the frequeny domain line shapes are losely approx-
imated by a Lorentzian funtion. Negleting oherene transfer ehoes, the
signal envelope of a 2D experiment an be assumed to have a biexponential
form [57℄
s(e)(t1, t2) = s
(e)(0, 0) exp (−λ(e)t1) exp (−λ(d)t2) (2.1)
with rates λ = 1/T2 in the evolution (e) and detetion (d) periods. Suh time-
domain envelope, deaying exponentially in both dimensions, laks ylindrial
symmetry about the origin t1 = t2 = 0. After a 2D Fourier transformation, the
orresponding 2D absorption peak shows a Lorentzian shape, whose setions,
taken parallel to either axis yield pure 1D absorption Lorentzian line shapes.
The asymptoti deay is proportional to (∆ω
(e)
tu )
−2
and (∆ω
(d)
sr )−2 on setions
parallel to one of the frequeny axes, while it is proportional to the inverse
fourth power in the biseting planes [with (∆ω
(e)
tu ) and (∆ω
(d)
sr ), frequeny
oset in evolution (e) and detetion (d) periods with respet to resonanes
ω
(e)
tu and ω
(d)
sr ℄. This lak of ylindrial or elliptial symmetry has been alled
"star eet", and an be removed by a 2D Lorentz-Gauss transformation [57℄,
whih yields a 2D absorption mode peak shape with ylindrial or elliptial
symmetry (Figure 2.1 and 2.2).
By using a weighting funtion
h(t1, t2) = exp (+λ1t1) exp (+λ2t2) exp (−σ21t21/2) exp (−σ22t22/2) (2.2)
with σ being an adjustable parameter, the envelope of Eq. 2.1 beomes
se(t1, t2) = s
e(0, 0) exp (−σ21(t21/2)) exp (−σ22(t22/2)). (2.3)
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Figure 2.1: 1D proles of Lorenztian and Gaussian peaks.
Figure 2.2: Removal of the so-alled "star eet" of a Lorentzian peak by a 2D Lorentz-
Gauss transformation.
After a 2D transformation, a Gaussian line shape is obtained
S(ω1, ω2) = s
(e)(0, 0)(
2pi
σ1σ2
) exp (−∆ω
2
1
2σ21
) exp (−∆ω
2
2
2σ22
). (2.4)
The ontours are irular for σ1 = σ2 and elliptial for unequal widths. It is
important to underline that 2D Lorentz-Gauss transformation is useful only if
the dispersive omponents in peaks with mixed phase are suppressed, and this
an be ahieved with pure phase spetra (i.e. either pure 2D absorption or
pure 2D dispersion peaks) [57℄. It must also be emphasized that the elliptial
symmetry of Gaussian signals is obtained only in phase-sensitive displays, and
if the absolute amplitude of a Gaussian signal is alulated, a peak shape is
obtained whih features again a star eet.
In most pratial appliations, the omplete analytial expression for a dis-
rete Fourier transform NMR spetrum is a sum of omplex, non-Lorentzian
funtions ([45, 59℄). However, if the aquisition time t2 is large, ompared
to the relaxation time of the slowest deaying resonane (t2 ≥ 1/R2,j), and
the sweep width is large ompared to the relaxation rate R2,j as well as the
frequeny range of the spetrum νj − ν, a true Lorentzian spetrum is ob-
tained [60℄. Nevertheless, this disrete Fourier transform spetrum requires
orretion of a pseudobaseline stemming from the rst point of the FID and of
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a frequeny-dependent phase distortion of the spetrum (for details see Refs.
[59, 45℄). Aordingly, a phased, baseplane orreted unsaturated resonane
line in solution is losely approximated by a Lorentzian funtion. Convolu-
tion of the time domain with exponential, sine, osine funtions, does not
alter the line shape after transformation [61℄, and preserves the frequeny of
its maximum. This shape has been useful in peak tting proedures applied
to experimental data [60℄. As stated above, a 2D Lorentzian line laks ylin-
drial or elliptial symmetry, whih an be ahieved by a 2D Lorentz-Gauss
transformation. Gaussian ltering transforms a Lorentzian frequeny-domain
funtion of width ω0 into a Gaussian frequeny-domain funtion of width ρω0,
where ρ is typially less than unity, and it has been found that ρ = 0.66 is
usually lose to optimum [62℄.
Bearing in mind the power of Lorentz-Gauss tranformation and the sym-
metry of the Gaussian line, the CAKE algorithm aims at integrating a peak
relying upon its axial symmetry, even when in drasti overlapping onditions.
The idea is that the volume an be estimated by integrating a non-overlapping
fration of the peak obtaining a reasonable approximation of volume in ases
where ross peaks overlap. Therefore the major assumption in this study is
that the Lorentzian signal is transformed into a Gaussian line by a Lorentz-
to-Gauss transformation. For in-phase peaks of TOCSY and NOESY spetra,
suh a transformation is well-suited, espeially onsidering that the multiplet
struture of the in-phase omponents is only barely resolved and a maximum
signal-to-noise ratio is usually required to detet even weak signals [57℄.
Figure 2.3A shows the ontour plot of a Gaussian peak. The arbitrary
angle AÔB (a "slie" seleted in a non-overlapping region and entered on
the enter of mass), denes the area AFi of a peak fration for eah i − th
level bound urve; suh an angle identies a frational volume VF in the three-
dimensional representation. Beause of the axial symmetry, for eah i−th level
the frational volume VF relates to the total volume VT as the frational area
of eah level relates to the orresponding total area ATi . From the equation
VT =
ATi
AFi
·VF, (2.5)
true for eah ouple of level bound areas, if Ri =
ATi
AFi
, the total volume of a
peak an be obtained by multiplying a frational volume by the orresponding
Ri fator.
It is ommon experiene that experimental 2D peak shapes are quite lose
to an ellipse. Therefore, Eq. (2.5) is still valid if the right angle AÔB delimits
1
4
of the ellipse by lying on the semimajor and the semiminor axes (Figure
2.3C).
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Figure 2.3: Contour plots of simulated isolated (A) and overlapping (B) Gaussian peaks.
In (A), the arbitrary angle AÔB denes a fration of the peak area, seleted in a non-
overlapping region, and entered on the enter of mass. In (B), AÔB and CK̂D selet a
fration of peaks 1 and 2, respetively. (C) Experimental Gaussian ross-peak. The right
angle AÔB selets a frational area orresponding to 1
4
of the total area.
In partiular, by dening the ellipse eentriity as e =
√
1− b2
a2
, where b and
a are the semiminor and the semimajor axes (assuming b < a), 0 ≤ e ≤ 1
and e = 0 in the ase of a irle. More generally, it an be demonstrated
that Eq. (2.5) applies with a good approximation to eentriity e ≤ 0.5,
whih orresponds to a dierene < 10% between axes, and a irle well
approximates the ellipse. For eentriity e > 0.5, Eq. (2.5) an be safely
used if the polygonal AÔB identies a region symmetrial with respet to
one of the semiaxes. The advantage of this approah beomes apparent for
overlapping Gaussian peaks. Here, the integration is biased by the presene
of the overlapping region that aets both volumes. In ontrast, the "slie"
AÔB of peak 1 (Figure 2.3B), seleted in a non-overlapping region, has very
little ontribution, if any, from peak 2, and therefore its frational volume an
mostly be attributed to peak 1. The same is true for CK̂D sliing peak 2
(Figure 2.3B), whose frational volume an mostly be attributed to peak 2.
Therefore, if we integrate the volume fration identied by AÔB and alulate
the orresponding R1 onstant, it should be possible to estimate the unbiased
volume of eah peak. From Figure 2.3B, the seond most internal (highest)
level of peak 1, essentially arises from peak 1, and the eet of peak 2 on that
level is negligible. Consequently, the R1 onstant an be obtained from the
ratio between the total area (AT1) and the frational area (AF1) of that level,
AT1/AF1. Analogously, for peak 2 the frational volume identied by CK̂D
an be onsidered, and its seond highest level an be hosen to obtain the
respetive fator R2 (Figure 2.3B).
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2.2.2 The R fator estimation
In order to estimate the R fator for a seleted fration of a peak, an internal
level attributable to the peak has to be hosen. Denoted by AT the total
level area and by AF the frational level area, the ratio R = AT/AF an be
obtained by a Hit-or-Miss Monte Carlo tehnique [63, 64℄. Let us denote by
(lxi, lyi), with i = 1, 2, ..., N, the vertex oordinates of the polygonal Plevel
relative to a ontour level, by (cx, cy) the oordinates of its enter point, and
by α1, α2 two rays with their ommon origins in (cx, cy). The frational area
AF is therefore dened by the intersetion of the polygon Plevel and the area
delimited by the rays (Figure 2.4). Furthermore, let us denote by lxmin and
lxmax the minimum and maximum lxi oordinates, and by lymin and lymax the
minimum and maximum lyi oordinates, respetively. Two pseudo random
numbers xr and yr are now uniformly extrated in the intervals [lxmin, lxmax],
and [lymin, lymax], respetively. The extration is ontinued until a number
NAT of points (xr, yr) is internal to the polygonal Plevel. If an extrated point
(xr, yr) is also inside the area AF, then the number of frational hits NAF is
augmented by one. Of ourse, being the (xr, yr) pairs uniformly extrated
in the retangle [lxmin, lxmax]×[lymin, lymax], the ratio R = AT/AF will be
estimated by the ratio R = NAT/NAF.
Figure 2.4: Total level area AT and frational level area AF dened by the intersetion
of the polygon Plevel and the area delimited by the rays α1, α2.
2.2.3 The Monte Carlo integration
In priniple, any method is suitable to integrate the seleted frational vol-
ume. However, the simple sum an be biased beause of the small region and
the limited number of points within the seleted area. Aordingly, the Monte
Carlo Hit-or-Miss tehnique appears to be more suitable. Let us denote by
(pxi, pyi), with i = 1, 2, 3, 4, the vertex oordinates of the quadrilateral Pbase,
whih is the base of a prism of height h and that ontains the frational volume
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VF (in partiular, px1 = cx, and py1 = cy, while other two points are hosen on
the α1 and α2 rays). Furthermore, let pxmin and pxmax be the minimum and
maximum pxi oordinates, and pymin and pymax the oordinates orrespond-
ing to the minimum and maximum pyi, respetively. Two pseudo random
numbers xr and yr are uniformly extrated in the intervals [pxmin, pxmax] and
[pymin, pymax], respetively. The extration is ontinued until the extration
number NPbase , whih represents the number of points (xr, yr), is internal to
the quadrilateral of base Pbase. If a point (xr, yr) is internal to the quadrilateral
of base Pbase and to the polygonal base Plevel, a ubi interpolation gives the
peak p(x, y) values in the point (xr, yr), and another pseudo random number
ρ is uniformly extrated in the interval [0, 1]. If ρ·h ≤ p(xr, yr), that is, if ρ·h
is a point internal to the fration volume VF, the number of volume hits NV is
augmented by one. If VP is the prism volume (Figure 2.5), alulated by the
software, then the frational volume VF is estimated as
VF = NV·VP/NPbase (2.6)
Figure 2.5: Prism of volume VP that ontains the frational peak volume VF .
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3.1 Introdution
NMR has found an inreasingly broad range of appliations in dierent elds
of researh ranging from physial and material sienes to hemistry, biol-
ogy, and mediine. Beause it interats with nulear spins by using very
weak eletromagneti elds, NMR is virtually the only tehnique that pro-
vides atomi-level information without disturbing the hemial properties of
the moleules and materials under investigation. This enormous versatility
has been possible beause of the development of a wide range of NMR tools
through the years. Among the major ahievements one should ite Fourier-
transform NMR that had a dramati eet on the experimental sensitivity of
NMR [65℄, and the introdution of multidimensional NMR spetrosopy by
Jeener [66℄ and Ernst [67℄ in early seventies.
In reent years, NMR spetrosopy faes a number of new hallenges, suh
as the investigation of the struture and dynamis of biologial moleules of
inreasing size and omplexity, the haraterization of protein-omplexes, as
well as the study of kineti features of biohemial proesses in the ell. This
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requires further tehnial and methodologial improvements in terms of ex-
perimental sensitivity, spetral and temporal resolution. New advaned NMR
pulse sequenes and aquisition shemes are thus required that make optimal
use of the improved instrumental performane, and are best adapted to the
sienti problems in mehanisti systems biology. It has to be pointed out
that the wide variety of methods reently developed for fast data aquisition
are mostly addressed to protein struture eluidation and protein-ligand ki-
neti investigations. Therefore, fast NMR aquisition shemes are shaped and
ongured on relatively large moleules. In suh ontext, this hapter will ex-
plore the appliation of a fast-pulsing NMR experiment for metaboli prole
haraterization, thus requiring the optimization of a reent pulse sequene for
fast HMQC aquisition, alled SOFAST-HMQC [2, 3℄ (band-Seletive Opti-
mized Flip-Angle Short Transient heteronulear multiple quantum oherene),
of small moleules suh as metabolites.
3.2 Fast multidimensional NMR spetrosopy
Multidimensional NMR experiments are ruial for the study of biomoleu-
lar struture and dynamis as they provide the required resolution to extrat
spetral parameters for individual nulear sites in the moleule. While in 1D
NMR the time evolution of nulear spin magnetization is deteted diretly
via the eletri urrent indued in a reeiver oil, the evolution in a so-alled
indiret time domain is monitored by stepwise inrements of a delay in the
pulse sequene. As a onsequene of this time inrements proedure, the
experimental time required for the aquisition of an nD NMR spetrum in-
reases by a. 2 orders of magnitude per additional dimension. Therefore,
even if the inherent sensitivity is suient, omplete sampling of the indiret
time domain grid imposes lower limits on the experimental times: several
minutes for 2D, several hours for 3D and so on. Therefore, new aquisition
shemes are required for a more rapidly data reording, taking are to obtain
a suient signal-to-noise ratio. In order to speed up multidimensional NMR
data aquisition, the sampling problem an be resolved either by limiting the
number of data points (sparse or non-uniform sampling tehniques), or by
reduing the duration of eah repetition of the experiment (fast pulsing teh-
niques). Most of the existing fast aquisition tehniques are based on the rst
solution, inomplete sampling of the indiret dimensional time spae. Ex-
amples are non-uniform data sampling ombined with non-linear proessing
shemes [68, 69℄, redued dimensionality or projetion NMR [70, 71, 72, 73℄,
and Hadamard NMR [74, 75℄ where data sampling is realized diretly in the
frequeny domain. All of these methods basially allow reording of multi-
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dimensional orrelation spetra in an experimental time ranging from a few
minutes up to several hours.
The ultimate solution to the NMR data sampling problem has reently
been proposed and experimentally demonstrated by Frydman and o-workers
[76℄. Their ingenious onept of "single-san" NMR allows reording of any
multidimensional NMR spetrum within a single repetition of the experiment.
Despite the high potential of single-san NMR for future biomoleular appli-
ations, this tehnique urrently requires a very high intrinsi sensitivity and
spetrometer hardware optimized for both NMR spetrosopy and imaging
purposes. On the other hand, for appliation to proteins in aqueous solu-
tion, several sans are generally required to yield good water suppression and
aeptable signal to noise in a few seonds of experimental time.
NMR fast pulsing tehniques present an alternative way to reduing aqui-
sition times. The main idea is to shorten the time delay between suessive
sans (reyle delay) to ahieve higher repetition rates and thus ollet the
same number of sans in less time. Of ourse, the number of data points to
be reorded an also be redued as disussed above, whih makes fast-pulsing
tehniques fully ompatible with sparse sampling approahes. A reyle delay
is required to allow relaxation of the exited spins (usually
1
H) towards their
thermodynami equilibrium, and to build up suient
1
H polarization to be
used for the next san.
In order to keep the experimental sensitivity high enough while using fast
repetition rates, some spetrosopi triks are required. A rst approah has
beome known as longitudinal relaxation enhanement [77℄. Suh method
is based upon the fat that the eieny of
1
H spin-lattie relaxation is in-
reased if nearby
1
H are unperturbed by the pulse sequene, so that they an
take up some of the energy put into the system via dipole-dipole interations
(nulear Overhauser eet, NOE), or via hydrogen exhange. In pratie, the
relaxation enhanement is realized by seletively manipulating a subset of the
proton spins of interest in a well dened spetral region throughout the pulse
sequene, thus ensuring that the spin states of all other protons that are not
diretly involved in the oherene transfer pathways of a partiular experi-
ment remain unperturbed. This yields redutions in eetive longitudinal
1
H
relaxation times from a few seonds to a few hundred milliseonds. In some
irumstanes, e.g., in HMQC experiments, the sensitivity of fast-pulsing ex-
periments an be even further enhaned by adjusting the exitation ip angle
to the soalled Ernst angle [57, 78℄. Both eets have been ombined in the
SOFAST experiment [2, 3℄ that allows one to reord 2D
1
H-
15
N or
1
H-
13
C or-
relation spetra of proteins in only a few seonds, thus opening new avenues for
real-time investigations of protein kinetis at atomi resolution. We explored
the potential of suh experiment for metaboli proling issue by applying it
28 Chapter 3. Fast NMR tehniques in metabonomis
to ell samples for fast detetion of metabolites.
3.3 SOFAST-HMQC
The introdution of SOFAST-HMQC sequene by Shanda and Brutsher
represents an alternative tehnique for fast aquisition of 2D heteronulear
orrelation spetra. The sequene is realized by using very short inter-
san delays therefore ombining the advantages of a small number of radio-
frequeny pulses, Ernst-angle exitation, and longitudinal relaxation optimiza-
tion [77, 79℄ to obtain an inreased signal to noise ratio for high repetition
rates of the experiment. Sine SOFAST-HMQC uses standard data sampling
in the indiret dimension, it has the further advantage of being therefore eas-
ily implemented on any ommerially available high-eld NMR spetrometer.
Figure 3.1 shows the basi pulse sheme to reord SOFAST-HMQC spetra.
Figure 3.1: SOFAST-HMQC experiment to reord
1
H-X (X=
15
N or
13
C) orrelation
spetra of proteins. Filled and open pulse symbols indiate 90
◦
and 180
◦
rf pulses, exept
for the rst
1
H exitation pulse applied with ip angle α. The variable ip-angle pulse has
a polyhromati PC9 shape, and band-seletive
1
H refousing is realized using an r-SNOB
prole. The transfer delay ∆ is set to 1/(2JHX), the delay δ aounts for spin evolution
during the PC9 pulse, and trec is the reyle delay between sans.
3.3.1 General aspets
This pulse sequene provides the required high sensitivity to perform fast
heteronulear
1
H-X orrelation experiments of maromoleules by using very
short reyle delays (trec). The main features of SOFAST-HMQC are the
following:
• The HMQC-type 1H-X transfer steps require only few rf pulses whih
limits signal loss due to B1-eld inhomogeneities and pulse imperfe-
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tions. Rf pulses redution will be espeially important if the experiment
is performed on a ryogeni probe, where B1-eld inhomogeneities are
more pronouned.
• The band-seletive 1H pulses redue the eetive spin-lattie relaxation
times (T1) of the observed proton spins. The presene of a large number
of non-perturbed
1
H spins, interating with the observed
1
H via dipolar
interations (NOE eet), signiantly redues longitudinal relaxation
times whereby the equilibrium spin polarization is more quikly restored.
• The adjustable ip angle of the proton exitation pulse allows further
enhanement of the available steady-state magnetization for a given re-
yle delay.
3.3.2 Ernst-angle exitation
The repetition rate of an NMR pulse sequene depends on the delay trec
between the rst pulse of one san and the rst pulse of the next san. If
the spin system is saturated by fast rf pulsing, short intersan delays (trec)
lead to a signiant loss in signal intensity. Ernst and o-workers developed
an elegant tehnique to optimize the sensitivity in fast pulsed 1D one-pulse
NMR experiments by the appliation of a non-90
◦
ip-angle [57℄, known as
the Ernst angle [80, 44℄. Maximal signal for an intersan delay trec, and
longitudinal relaxation time T1, is obtained by the appliation of an exitation
angle βErnst given by:
cos(βErnst) = exp(
−trec
T1
) (3.1)
T1 is the eetive spin-lattie relaxation time onstant assuming mono-
exponential polarization reovery. The longitudinal equilibrium magnetiza-
tion Meq in dependene of the thermal equilibrium magnetization M0 is
Meq = M0
(1− exp(−trec/T1))
(1− exp(−2trec/T1)
(3.2)
The signal resulting from a single rf pulse applied to Meq with a ip-angle
βErnst is
Signal = Meq sin(βErnst) (3.3)
and the signal-to-noise ratio per measurement time, referred to as the sensi-
tivity of the single pulse experiment [57℄, is
Sensitivity = Signal/
√
trec (3.4)
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In the ase of SOFAST-HMQC sequene (Figure 6.1) Equation 3.1 beomes
cos(βErnst) = exp(
−Trec
T1
) (3.5)
with Trec the eetive
1
H longitudinal relaxation delay inluding the inter-
san delay (trec), the aquisition times t1/2 and t2 , and the transfer delay ∆
(Figure 6.1) and the S/N per unit experimental time, negleting transverse
spin relaxation eets and other soures of signal loss, is then given by
S/N ∝ (1− exp(−Trec/T1))
1− exp(−Trec/T1) cos(β)
· sin(β)√
nTScan
(3.6)
with β the eetive ip angle β = α−180◦ taking into aount the eet of the
1
H refousing pulse, and TScan the time required for a single san inluding
the pulse sequene duration, aquisition time, and the inter-san delay (trec).
3.3.3 Proton band-seletive pulses
The performane of SOFAST-HMQC ritially depends on the hoie of the
pulse shapes for the band-seletive exitation and refousing pulses on the
1
H hannel. Atually, the longitudinal relaxation optimization enhanement
eet is stritly related to the number and type of the applied proton pulses.
For this purpose, Shanda and o-workers [3℄ used only 2 (band-seletive)
1
H
pulses in SOFAST-HMQC thus ensuring minimal perturbation of the unde-
teted proton spins, and providing higher enhanement fators than observed
with other longitudinal relaxation optimized pulse shemes [77℄. More over,
sine the water resonane is outside the seleted
1
H pulse bandwidth, the
WATERGATE-type [81℄ pulse sequene element G1-180
◦
(
1
H)-G1 (Figure 6.1)
yields eient water suppression within a single san. The seletive proton
manipulation also removes oupling evolution between exited
1
H spins and
passive
1
H spins from frequeny bands that are not perturbed by the seletive
pulses.
As spin refousing pulse, Shanda and o-workers [3℄ rst hose r-SNOB
prole [82℄ for it presents the advantage of a short pulse length thus redu-
ing signal loss due to transverse spin relaxation [2℄. Afterwards, they tested
other pulse shapes and found that, for
1
H-
15
N orrelation spetra, a REBURP
(Figure 3.2) prole yields higher sensitivity despite a 3-times longer pulse du-
ration. Experimental omparison of r-SNOB and REBURP performane in
1
H-
15
N SOFAST-HMQC showed signal inrease of up to 50% observed when
using REBURP instead of r-SNOB for short san times. Suh result depend on
better o-resonane performane of REBURP, resulting in less perturbation
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of the aliphati
1
H spin polarization and, as a onsequene, shorter longitudi-
nal relaxation times of the amide proton spins.
Figure 3.2: Exitation shaped pulses proles. A) PC9 pulse; B) RE-BURP pulse.
The most band-seletive "top-hat" pulse shapes ommonly used for NMR
spetrosopy, e.g. BURP [83℄, Gaussian pulse asades [84℄, or SNOB [82℄,
have only been optimized for disrete ip angles of 90
◦
or 180
◦
, and generally
are not useful for variable ip angle exitation purposes. In ontrast, polyhro-
mati (PC) seletive pulses have been shown to perform well for a whole range
of ip angles [85℄. These PC pulses are based on a series of simultaneously
applied, frequeny shifted basi pulse elements. For the SOFAST appliation,
Shanda and o-workers used the PC9 exitation pulse shape (Figure 3.3),
whih has the required "top-hat" exitation prole for ip angles 0
◦
<α<120◦.
Moreover, unlike other band-seletive exitation pulses that yield "pure-
phase" transverse magnetization, the PC9 pulses produe phase that is a linear
funtion of the frequeny oset. So, Shanda and Brutsher proposed to replae
a PC9 pulse by the ombination of a pure-phase exitation pulse followed by
a delay δ. The hemial shift and salar JHX oupling evolution ourring
during this delay δ an be aounted for by adjusting the subsequent transfer
delay of the HMQC sequene to 1/(2JHX)− δ (Figure 6.1). If the delay δ has
been properly adjusted prior to data aquisition no rst-order phase orretion
is required in the
1
H dimension. Otherwise, pure-phase spetra an still be
obtained by applying a rst order phase orretion.
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Figure 3.3: Simulated frequeny-domain response of the polyhromati pulse PC9
onsisting of nine radiofrequenies spaed ∆f = 1/T apart with relative intensities of
1:2:2:2:2:2:2:2:2:1. A) Absorbtion; B) dispersion.
3.3.4 Appliation to protein
The SOFAST-HMQC pulse sequenes of Figure 6.1 have been designed to
provide high sensitivity for fast repetition rates. To examine the performane
of the SOFAST-HMQC experiment for the desired short intersan delays,
Shanda and o-workers measured 1D spetra of
15
N-labeled ubiquitin. Fig-
ure 3.4 shows the measured S/N ratios for onstant experimental time as a
funtion of the duration of a single repetition of the experiment Tscan (tak-
ing into aount the length of the pulse sequene, data aquisition time, and
reyle delay) for ubiquitin sample aquired at 600 MHz on a spetrometer
equipped with a standard probe (Figure 3.4a) and at 800 MHz on a spe-
trometer equipped with ryoprobe (Figure 3.4b). Suh spetra provide only
information on the average signal to noise ratio obtained by the dierent
pulse sequenes. Eah intensity point was obtained by saling all spetra to
the same noise level aording to the number of applied sans, and integrating
the spetral intensity over the range 7.0-9.5 ppm. The urves are therefore
representative of the average behavior of the experiment for all amide sites in
the protein.
The SOFAST-HMQC data (Figure 3.4) for three dierent ip angles (90
◦
,
120
◦
, and 150
◦
) are ompared to results from a sensitivity-enhaned (se) water-
ipbak (wfb) HSQC pulse sequene, and from a longitudinal relaxation op-
timized HSQC (LHSQC) experiment [77℄.
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Figure 3.4: Signal-to-noise ratios per unit time (intensity) plotted as a funtion of the
san time (Tscan) obtained with dierent
1
H-
15
N orrelation experiments for (a) ubiquitin
(8.6 kDa, 2 mM, 25
◦
C, pH 6.2) at 600 MHz, (b) ubiquitin at 800 MHz. The intensities
were extrated from 1D spetra reorded using the SOFAST-HMQC sequene of Figure 6.1
(t1=0) with ip angles of a α= 90
◦
(), 120
◦
(N) and 150
◦
(◦), LHSQC (▽), and se-wfb
HSQC (•). Band-seletive 1H pulses in the SOFAST-HMQC and LHSQC experiments were
entered at 8.0 ppm overing a bandwidth of 4.0 ppm. Variable ip angle exitation and
refousing in SOFAST-HMQC were realized using a PC9 pulse of 3.0 ms and a REBURP
pulse of 2.03 ms, respetively.
The prinipal onlusions from those experimental results are the follow-
ing:
• Using optimized aquisition parameters (san time, ip angle) and mod-
erate t1 aquisition times, SOFAST-HMQC yields the most sensitive
1
H-
15
N orrelation spetra of folded proteins.
• SOFAST-HMQC provides a muh higher sensitivity than se-wfb-HSQC
using the same san times, and a similar sensitivity as se-wfb-HSQC
reorded with optimized inter-san delays.
The SOFAST features showed in Figure 3.4 ould be used as guidelines for
setting up SOFAST-HMQC experiments. For pratial appliations the au-
thors reommended to x the san time (reyle delay) and then optimize the
ip angle of the PC9 exitation pulse experimentally by reording a series of
1D SOFAST-HMQC spetra varying the power level (ip angle) of the PC9
pulse.
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3.4 Real-time ell
1
H-
15
N metaboli prole
NMR is a well-established tehnique for monitoring metabolism in living ells.
They are often investigated by 1D NMR spetrosopy, therefore beneting of
real-time measurements sine all spetral frequenies are exited by a single
san. However, 1D NMR laks the resolution needed to ope with the degen-
eray of the NMR resonane frequeny and a reasonable S/N ratio, the latter
beause of the short aquisition time required for the short lifetime of samples.
The lak of resolution an be irumvented by 2D spetrosopy that, ompared
with 1D, does yield higher resolution, but is intrinsially time-onsuming be-
ause data aquisition for the seond dimension spans at least several minutes.
As disussed before, the total experimental time will be given by the produt
of the number of sans Nscan, required for a proper sampling of the indiret do-
main, and the single-san duration (the repetition time) Tscan, whih inludes
the spin relaxation time neessary to restore the thermal equilibrium before
the next additional measurement. This reyle delay is therefore assoiated
with the
1
H spin-lattie relaxation time T1, and, depending on its duration,
aquisition times an be of the order of minutes, yielding total experimental
times of hours.
Cells are able to survive and stay suspended in the solvent medium for
several hours, but, after only few minutes, oxygen starvation hanges their
metabolism and dereases the ytoplasmi pH [86℄. Therefore, long aquisition
times may detet small moleules originating from an "average" metabolism
that does not orrespond to the physiologial state of the ell. For sam-
ples with short lifetime data aquisition must be rapid, and fast-aquisition
2D tehniques, as those used to study the struture and dynamis of pro-
teins in solution are required [87℄. Two dierent strategies have been put
forward for fast aquisition spetrosopy: the "single-san" NMR [76, 88℄ and
the SOFAST-HMQC. The single-san approah is able to reord any multi-
dimensional NMR spetrum within a single repetition of the experiment, but
with urrent spetrometer hardware it typially laks in sensitivity, resolution,
and/or suient gradient strength over extended periods of time. Alterna-
tively, the SOFAST method is able to drastially redue Tscan by relaying on
aelerated T1 of the spins of interest [77℄ and on optimized ip-angles (e.g.,
the Ernst angle [57℄) to enhane the steady-state magnetization of the exited
spins [78℄. As pointed out in the previous setion, Brutsher and o-workers
have ombined these features into single 2D and three-dimensional NMR pro-
tools [2, 3, 89, 90℄, showing that it is possible to redue Tscan down to 100 ms,
obtaining 2D
1
H-
15
N or
1
H-
13
C orrelation spetra in the range of seonds
and with high S/N ratio.
Beause of its adaptability to routine spetrometers, we have investigated
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the possibility of using the SOFAST-HMQC approah to explore ellular
metabolism in
15
N-labeled ells. In Chapter 6 we report that the SOFAST ex-
periment allows aquisition of 2D
1
H-
15
N orrelation spetra of small metabo-
lites diretly in living ells in few seonds, with a high S/N ratio, therefore
aording a piture of the "instantaneous" in-ell metabolism. In partiular,
we have applied the SOFAST-HMQC experiment to
15
N-labeled diatoms ells,
whih are uniellular algae with siliied ell walls.
Figure 3.5: Thalassiosira rotula image from SEM mirosope.
They are at the base of the marine food web, and are the major ontributors
to phytoplankton biomass worldwide. In response to favorable light and nutri-
ent onditions, diatoms rapidly divide and form large blooms, and as blooms
propagate, nutrients are depleted, growth eases, and ells sink to the deep
oean. The sinking diatom blooms fuel the biologial arbon pump and export
arbon from the atmosphere to the deep oean. Despite this, little is known
about the moleular underpinnings of diatom biology. As a part of a long-
running projet, we have reently undertaken a study of the metaboli prole
of Thalassiosira rotula (Figure 3.5) to understand how diatoms aquire nutri-
ents, how they respond to stress, and how they ativate hemial defense and
hemial signaling that regulates algal bloom. Although useful information
an be ahieved by investigating the metaboli prole of polar and lipophili
extrats, in-vivo studies of T. rotula ells in (artiial) sea water are expeted
to yield a more reliable understanding of the metaboli pathways.
On the other hand, the presene of salt in the artiial sea water ulture
medium, used to suspend the ells in the NMR tube, will ause resonane
broadening, and this, together with the degeneray of the resonane frequeny,
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will make 1D spetrosopy useless. T. rotula ells an easily be ultured on
unlabeled and
15
N-labeled media, and this warrants that a suient number
of olonies an rapidly be obtained to test the potential appliation of the
SOFAST-HMQC sequene to
15
N-labeled ells. The 2D orrelation spetra
obtained for T. rotula ells in 10-15 seonds with a high S/N ratio suggest
that fast aquisition tehniques introdued for proteins an be easily extended
to other living ell systems, monitoring the metabolism under physiologial or
stressing onditions in the emerging elds of metabolomis and metabonomis
[91, 35℄.
Chapter 4
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lear Magneti Resonane spetrosopy. Eur Respir J 2008; 32:
1-9.
4.1 Materials and methods: a) hepatoellular
arinoma
Speimens olletion
Liver tissues were olleted from patients with diagnosis of hepatoellular ar-
inoma (HCC) developed on liver hepatitis C virus (HCV) related irrhosis
(CIR) or liver metastasis from oloretal arinoma (MET-CRC). The por-
tions of the surgially exised samples that were addressed to NMR spe-
trosopy onsisted of HCC tissues (HCC; N = 17), with the orresponding
38 Chapter 4. NMR metaboli prole experiments
HCV -related irrhoti tissues (CIR; N = 17), tissues from liver metastases
(MET-CRC; N = 9), and the orresponding adjaent non-irrhoti liver tis-
sues plus two liver tissues from healthy subjets (NT; N = 11). All samples
were frozen in liquid nitrogen in order to immediately "quenh" any metaboli
reation and preserve metabolite onentrations. Tissues were stored at -80
◦
C until extration to prevent any metaboli deay. Pathologial evaluation
was performed on eah ase, histopathologial lassiation was based on the
riteria of World Health Organization; disease status at the time of diagno-
sis was dened depending on linial staging as assessed by medial history,
physial examination, and instrumental tests. A written informed onsent for
tissue sampling was obtained before the analysis from aner patients. The
study was reviewed and approved by the ethial review board at the National
Caner Institute - G. Pasale Foundation - of Naples. The main harateristis
of aner patients are presented in table of Figure 4.1 .
Sample preparation
Tissues were mehanially disrupted to deproteinize the sample and perma-
nently halt the metabolism. The proedure allowed extration of only the
metabolites of interest (e.g., lipids, arbohydrates, amino aids and other small
metabolites) while leaving others ompounds (e.g., DNA, RNA, proteins) in
the tissue pellet. Combined extration of polar and lipophili metabolites
was arried out by using methanol/hloroform as suggested by the Standard
Metaboli Reporting Strutures working group [92℄. It appears to be the pre-
ferred hoie for metabonomi NMR studies onsidering yield, reproduibility,
ease and speed, as perhlori aid extrats show a large sample-to-sample vari-
ation [93℄, espeially for partiularly lipid-rih tissues suh as liver and brain
[93, 94℄. Homogenization of 30 mg of frozen tissue samples was arried out
in 8 ml/g of wet tissue of methanol and 1.70 ml/g per wet tissue of water
(all solvents were old) with UltraTurrax for 2 min on ie. Then, 4 ml/g wet
tissue of hloroform were added and the homogenate was stirred and mixed,
on ie, deliately using an orbital shaker for 10 min (the solution must be
mono-phasi). Then, other 4 ml/g wet tissue of hloroform and 4 ml/g wet
tissue of water were added and the nal mixture was shaken well and en-
trifuged at 12000 g for 15 min at 4
◦
C. This proedure separates three phases:
a water/methanol phase at the top (aqueous phase, with the polar metabo-
lites), a phase of denatured proteins and ellular debris in the middle and
a hloroform phase at the bottom (lipid phase: with lipophili ompounds).
The upper and the lower layers of eah sample were transferred into glass vials
and the solvents were removed under a stream of dry nitrogen and stored at
-80
◦
C until required. For one-dimensional (1D) and two-dimensional (2D)
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homonulear NMR experiments the polar extrats were resuspended in 700 µl
Phosphate Buer Saline (PBS, pH 7.4) with D2O 10% for lok proedure, and
then transferred in an NMR tube. For 2D heteronulear
1
H-
13
C experiments,
the polar fration was resuspended in 700 µl of D2O.
NMR measurements
1D spetra were reorded at 600.13 MHz on a Bruker Avane-600 spetrome-
ter, equipped with a TCI CryoProbe
TM
tted with a gradient along the Z-axis,
at a probe temperature of 27
◦
C and aquired at the Institute of Biohemial
Chemistry in Pozzuoli (Napoli). 1D proton spetra were aquired by using
the exitation sulpting sequene [95℄. We used a double-pulsed eld gradi-
ent eho, with a soft square pulse of 4 ms at the water resonane frequeny,
with the gradient pulses of 1 ms eah in duration, adding 1024 transients of
16384 points with a spetral width of 7002.8 Hz. Time-domain data were all
zero-lled to 32768 points, and prior to Fourier transformation, an exponen-
tial multipliation of 0.6 Hz was applied. Clean total orrelation spetrosopy
(TOCSY) [96, 97, 98℄ spetra were reorded using a standard pulse sequene,
and inorporating the exitation sulpting sequene for water suppression.
In general, 320 equally spaed evolution-time period t1 values were aquired,
averaging 4 transients of 2048 points, with 7002.8 Hz of spetral width. Time-
domain data matries were all zero-lled to 4096 points in both dimensions,
thus yielding a digital resolution of 3.42 Hz/pt. Prior to Fourier transforma-
tion, a Lorentz-to-Gauss window with dierent parameters was applied for
both t1 and t2 dimensions for all the experiments. TOCSY experiments were
reorded with spin-lok period of 64 ms, ahieved with the MLEV-17 pulse
sequene. Spetra were referred to 0.1 mM sodium trimethylsilylpropionate
(TSP), assumed to resonate at δ= 0.00 ppm. The natural abundane 2D 1H-
13
C Heteronulear Single Quantum Coherene (HSQC) spetra were reorded
on the Avane-600 spetrometer operating at 150.90 MHz for
13
C, using an
eho-antieho phase sensitive pulse sequene using adiabati pulses for de-
oupling [99, 100℄. 128 equally spaed evolution time period t1 values were
aquired, averaging 48 transients of 2048 points and using GARP4 for deou-
pling. The nal data matrix was zero-lled to 4096 in both dimensions, and
apodized before Fourier transformation by a shifted osine window funtion in
t2 and in t1. Linear predition was also applied to extend the data to twie its
length in t1. Spetra were referred to the latate doublet (βCH3) resonating
at 1.33 ppm for
1
H, and 20.76 ppm for
13
C.
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Figure 4.1: Charateristis of aner patients (*AFP, alpha-fetoprotein).
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Statistial and multivariate data analysis
High resolution
1
H-NMR spetra were automatially data redued to inte-
grated regions ("bukets") having equal width of 0.04 ppm over the spetral re-
gion between 0.04 and 9.40 ppm by using AMIX 3.6 software pakage (Bruker
Biospin, Germany). The residual water resonane region (4.72 - 5.10 ppm)
was exluded and the integrated region was normalized to the total spetrum
area. To dierentiate liver tissues through NMR spetra, we arried out a mul-
tivariate statistial data analysis using projetion methods. The integrated
data redued format of the spetra was imported into SIMCA-P+ 12 pakage
(Umetris, Umea, Sweden), and Prinipal Component Analysis (PCA) and
Orthogonal Projetion to Latent Strutures Disriminant Analysis (O2PLS-
DA) were performed. Mean-entering was applied as data pre-treatment for
PCA, while Pareto saling and mean-entering were used prior to O2PLS-DA.
Both the ANOVA and the t-test were used for statistial analysis of the signals
seleted for quantiation.
4.2 Results
NMR experiments
NT, CIR, HCC and MET-CRC underwent a dual-phase extration, and the
aqueous frations were investigated by high-resolution NMR. Typial spe-
tra of NT (trae A), CIR (trae B), HCC (trae C) and MET-CRC (trae
D) are reported in Figure 4.2. Although isolated resonanes an readily
be assigned to spei metabolites by omparing their hemial shifts with
literature data [101, 102℄, line overlapping prevented the omplete spetral
identiation. This required homo- and heteronulear 2D experiments suh
as TOCSY (Figure 4.3) to identify
1
H-
1
H onnetivities, and
1
H-
13
C HSQC
(Figure 4.4) for diretly bonded
1
H and
13
C nulei. Thus, we were able to
identify all resonanes by a omparison with literature data and with NMR
spetra of standards aquired in separate experiments. The
1
H assignments
are reported in table of Figure 4.5. Inspetion of 4.2 shows lear visible dif-
ferenes among NT, CIR, HCC and MET-CRC. The spetral region from 0.5
to 3.00 ppm ontains signals assigned to leuine, valine, threonine, alanine,
lysine, glutamate, glutamine, and some organi aids suh as latate, aetate
and suinate. The region from 3.0 to 4.5 ppm inludes signals attributed to
reatinine, holine, arginine, phosphoethanolammine, phosphoholine, gly-
erolphosphatidilholine, α-gluose, trimethylamine-N-oxide, glyine, glyogen,
myo-Inositol and glyerol, and represents the most variable region. The 4.5-
7.5 ppm region, together with the residual water signal eliminated by the
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spei pulse-sequene used in the experiment, ontains the resonanes of β-
gluose, fumarate, tyrosine, histidine and phenylalanine. The region 5.5-6.4
ppm does not ontain signals, and as suh it has been omitted from 4.2.
Figure 4.2: Representative aliphati
1
H-NMR spetra of all liver tissue extrats used in
this study (spetra saled to TSP): (A) ontrol non-tumoral adjaent to metastasis (NT)
and (D) metastasis from the same patient (MET-CRC); (B) irrhoti adjaent to HCC
(CIR) and (C) HCC from the same patient (HCC). Numbers labels: 1, Leuine; 2, Valine;
3, Threonine; 4, Latate; 5, Alanine; 6, Lysine; 7, Aetate; 8, Glutamate; 9, Glutamine;
10, Suinate; 11, Creatine; 12, Choline; 13, Arginine; 14, Phosphoethanolamine; 15, Phos-
phoholine; 16, Glyerophosphoholine; 17, β-Gluose; 18, Trimethylamine-N-oxide; 19,
Glyine; 20, Glyogen; 21, myo-inositol; 22, Glyerol; 23, α-Gluose; 24, Fumarate; 25,
Tyrosine; 26, Histidine; 27, Phenylalanine.
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Figure 4.3: Typial TOCSY spetrum of HCC extrat sample; for metabolites identia-
tion see Figure 4.5 aption.
Figure 4.4: Example of
1
H-
13
C HSQC spetrum of HCC sample; for metabolites identi-
ation see Figure 4.5 aption.
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Figure 4.5: List of
1
H and
13
C hemial shift (δ, ppm) of metabolites found in 1H-
TOCSY and
1
H-
13
C-HSQC-NMR spetra of HCC, metastasis and adjaent non-involved
liver tissues.
a
Abbreviations: GPC, glyerophosphoholine; PC, phosphoholine; PE,
Phosphoryl-ethanolamine; TMAO: Trimethylamine-N-oxide. * Expeted hemial shift.
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Prinipal Component Analysis
Notwithstanding the use of 2D spetra, visual inspetion alone did not war-
rant meaningful observations of the metabolite distribution. To obtain sta-
tistially relevant biohemial information from NMR data, we rst applied
multivariate data analysis based on pattern reognition methods to all spetra
by omparing eah tissue with the anothers. Therefore, we applied PCA on
spetra of NT and CIR in order to evaluate their metabolomi proles. Figure
4.6 shows the PCA results as sores (Figure 4.6A) and loadings plots (Fig-
ure 4.6B) for the rst two prinipal omponents from spetra of CIR (lled
squares, ) and NT samples (empty squares, ).
Figure 4.6: PCA omparison of non-tumoral (NT) with irrhoti tissues (CIR). (A) Sores
plot (R
2
=73.14%) for CIR () and NT (). The major metaboli signals that dierentiate
the two lasses are shown in the loadings plot (B), where numbers refer to metabolites as
labeled in Figure 4.2.
Clustering is observed from the sores plot PC1 vs. PC2 (Figure 4.6A), where
PC1 and PC2 explained 73.14% of the total variane within the data. The
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metaboli signals responsible for the dierentiation of the two lasses an be
identied from loadings plot (Figure 4.6B) assoiated with the PCA. Com-
pared with NT tissue extrats, CIR showed inreased onentrations of latate
(Figure 4.2 for labeling), α-/β-gluose, and glyogen, with dereased onen-
tration of Thr, aetate, Glu, Gln, reatine, PC, GPC, TMAO, and myo-
Inositol. Applying PCA to the spetra of liver metastasis (), they resulted
separated from those orresponding to non-irrhoti normal liver (), as de-
pited in the sores plot PC1 vs. PC2, whih explains 90.78% of the total
variane (Figure 4.7C). The loadings plot in Figure 4.7D shows the major al-
terations of the metaboli signals responsible for the separation. In partiular,
metastasis dierentiated from the non-irrhoti normal liver for high level of
Leu, Thr, latate, Ala, aetate, Glu, Gln, Gly, GPC, PE, and myo-Inositol,
and for lower level of α-/β-gluose and glyogen.
Figure 4.7: PCA omparison of non-tumoral (NT) with metastasis tissues (MET-CRC).
The sores plot C (R
2
=90.78%) distintly shows a separation for metastasis () and non-
irrhoti () tissues along the PC1 axis. The loadings plot (D) shows the major signals that
determined dierene in the lustering, numbers refer to metabolites as labeled in Figure
4.2.
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As it an be seen in the sores plot (Figure 4.8A), PCA suessfully lassi-
ed HCC tissues () from the CIR strains () through two PCA omponents,
whih explained 70.93% of the variane within the dataset. The separation
was due to an inrease of Leu, Thr, latate, Ala, aetate, Glu, Gln, PC+GPC
and PE, and to a derease of reatine, α-/β-gluose and glyogen in HCC
(Figure 4.8B).
Figure 4.8: PCA omparison of HCC with irrhoti tissues (CIR). HCC () and the
orresponding irrhoti () samples separated in the sores plot A (R
2
=70.93%) along the
PC1 axis, by means of the loadings plot B. Numbering as in Figure 4.2 aption.
Furthermore, we readily distinguished HCC () from metastases (), as
shown by the sores plot PC1 vs. PC2, where the two omponents explained
83.79% of the total variane within the data (Figure 4.9C). The assoiated
loadings plot shows dierenes of the metabolite onentration whih deter-
mined suh lustering (Figure 4.9D). Compared to metastasis, HCC tissues
had higher levels of α-/β-gluose and glyogen, with lower levels of Leu,
Thr, latate, aetate, Glu, reatine, TMAO, myo-Inositol, Gly, GPC and
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PE. Finally, we performed PCA of the whole dataset by extending pattern
Figure 4.9: PCA omparison of HCC with metastasis tissues (MET-CRC). The sores
plot C (R
2
=83.79%) displays HCC spetra () and metastasis () spetra in two lusters
along the PC1 axis aording to the signals in the loading plot D, whih highlights the
signals involved in the lustering. Numbering as in Figure 4.2 aption.
reognition tehnique to all lasses. Figure 4.10 shows the sores plot PC1 vs.
PC2 and explains 77.94% of the total variane.
Although lusterings displayed in Figures 4.6, 4.7, 4.8 and 4.9 learly sep-
arated dierent pairs of hepati tissues, the whole model is more ontroversial
as it appears in the satter plot of Figure 4.10. For that reason we performed
an OPLS-DA analysis.
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Figure 4.10: PCA showing the metaboli dierenes within eah individual group of
tissues, namely NT (N), CIR (), HCC () and MET-CRC (△).
Orthogonal Projetion to Latent Strutures Disriminant
Analysis
To better onstrut a four tissue lasses model and to understand the role of
the X variables ("bukets") in the lass separation, and to prove the potential
of the NMR representation in assigning new samples to a spei lass, we
onstruted an O2PLS-DA model, whih resulted in three preditive and three
orthogonal omponents (R
2
=0.65 and Q
2
=0.35).
Figure 4.11: 3D sore plot showing the lass separation of the dierent group of tissues,
namely NT (blue), CIR (red), HCC (yellow) and MET-CRC (green).
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In the 3D sore plot (Figure 4.11) the four tissue lasses appear suiently
separated in lusters, although the model seems to be robust for the MET-
CRC samples (R
2
=0.82 and Q
2
= 0.63), but weaker for the HCC (R
2
=0.55
and Q
2
=0.26) and CIR samples (R
2
=0.58 and Q
2
=0.17). However, the latent
struture orresponding to the preditive part of the model an be used to
explain the relationships between X-variables and lass separation.
The p(orr)/q(orr) plot (Figure 4.12) is a useful tool to identify the vari-
ables responsible for the tissues lass separation. The pi(orr)j parameter is
the orrelation oeient between the ti preditive sore vetor and the Xj
variable, and an be onsidered as a measure of the similarity between the ti
sore vetor and the Xj variable. On the other hand, the qi(orr)j parameter
orresponds to the orrelation oeient between the ti preditive sore vetor
and the dummy variable representing the lass j, and allows its representation
in the same plot of the X variables. Figure 4.12 indiates that the rst prin-
ipal omponent is very similar to variables orresponding to "bukets" 1.34,
4.10, 3.90 and 3.82 ppm. In partiular, a progressive inrease of the 1.34 ppm
variable an be observed starting from the NT lass, through the CIR and
the HCC up to the MET-CRC samples (Figure 4.13A). On the ontrary, the
3.90 ppm variable shows an opposite trend through the four lasses (Figure
4.13B).
Figure 4.12: Identiation of variables responsible for the tissues lass separation:
pq(orr) plot with all variables ("bukets").
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Figure 4.13: Identiation of variables responsible for the tissues lass separation. (A)
and (B) variation of the "bukets" relative to the most signiant signals at 1.34 ppm
(latate) and 3.90 ppm (α-gluose), respetively, showing a progressive inrease of the 1.34-
ppm variable, and a orresponding derease of the 3.90-ppm variable. Samples are identied
by a olor ode.
In order to build a Naïve Bayes lassier the three preditive sore vetors
were used to obtain a new representation of the sample spae. The predition
performane of the lassier was evaluated by omplete ross-validation (four
groups). It showed just 7.4% of inorret predition (4/54 samples), while
92.6% of samples were orretly predited (50/54 samples). The four samples
were inorretly lassied as belonging to adjaent lasses: one NT sample
was predited as CIR (1/11 NT); two CIR samples were predited as HCC
(2/17 CIR), and one HCC was predited as MET-CRC (1/17). For a two-
lass model, O2PLS-DA is able to obtain a powerful lassiation and detet
potential markers [14℄. In this ase, only one omponent is needed to explain
the variation between the two lasses, and the preditive sore vetor t an
diretly be used to highlight resonanes ("bukets") ating as potential mark-
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ers. This ould easily be ahieved by building the S-plot, in whih p(orr)
is plotted against the preditive loading vetor p of the model, and only the
variables having an absolute p/perr ratio > 1.7 (where perr is the error on p
estimated by jak-knife in ross-validation) will be onsidered.
Figure 4.14: S-plots reporting p(orr) against the preditive loading vetor p of the model:
(A) NT vs. HCC; (B) NT vs. MET-CRC. All models indiated the signals at 1.34 and 3.90
ppm, as the prinipal disriminating variables.
Figure 4.15: S-plots reporting p(orr) against the preditive loading vetor p of the model:
(C) CIR vs. MET-CRC; and (D) HCC vs. MET-CRC. All models indiated the signals at
1.34 and 3.90 ppm, as the prinipal disriminating variables.
Six models were onsidered, eah orresponding to a pair of sample lasses.
Figure 4.14 shows the S-plots of NT vs. HCC (panel A) and NT vs. MET-
CRC (panel B) while Figure 4.15 shows the S-plots of CIR vs. MET-CRC
(panel C) and HCC vs. MET-CRC (panel D). All models indiated the signals
at 1.34 and 3.90 ppm, stemming from the latate and the gluose, respetively,
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as the prinipal variables disriminating both MET-CRC and HCC from NT
samples, and CIR and HCC from MET-CRC. These models an all be onsid-
ered robust having high Q
2
values (> 0.69). On the ontrary, the NT vs. CIR
and the CIR vs. HCC models did not show any disriminating variable as
a putative marker. Table reported in Figure 4.16 summarizes all parameters
related to the O2PLS-DA models.
Figure 4.16: Summary of O2PLS-DA parameters from the six pairs of models analyzed.
a
No disriminating variables were found as a putative marker.
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If a partiular lass an be onsidered as a ontrol, it is possible to gain
information about the variables that disriminate eah lass, with respet to
the ontrol, using the so alled SUS-plot (Shared and Unique Struture plot).
Assuming the NT samples as ontrol, the p(orr) vetors estimated for eah
two lasses models, separately inluding the NT lass, were used to represent
the X-variables in the SUS-plot (Figure 4.17). Sine the NT vs. CIR model
was not robust enough to be understood in terms of single variables, we limited
our analysis to NT, HCC and MET-CRC lasses. We found that the same
signals separate both HCC and MET-CRC samples from the ontrol, while
no unique signals disriminate these two lasses. In partiular, the bukets
loated at 1.30-1.38 ppm and 4.00-4.14 ppm; whih ontain the latate signals,
are elevated in both HCC and MET-CRC lasses, suggesting the latate as the
putative marker. On the ontrary, the bukets at 3.70-4.00 ppm, ontaining
the gluose signals, are prominent in NT lass, suggesting the gluose as the
putative marker. Therefore, both metabolites primarily ontribute to the
lassiation of the dierent groups, showing an opposite trend among the
groups. In partiular, the latate level inreases from NT group, through CIR
and HCC, to reah the highest value in the liver MET. On the ontrary, the
signals of gluose progressively derease from NT group, through CIR, HCC
and MET-CRC group, whih shows the lowest intensity.
Figure 4.17: SUS plot of NT, HCC, and MET-CRC lasses. Assuming the NT samples
as ontrol, the p(orr) vetors estimated for eah two lasses models, separately inluding
the NT lass, were used to represent the X-variables.
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Quantiation and statistial signiane
To onrm the parallel trend of these two putative markers (inreased latate
and dereased gluose), we integrated the
1
H-NMR isolated signals of la-
tate (βCH3, 1.33 ppm) and α-gluose (C1H, 5.24 ppm) in all tissue samples.
We only onsidered the α-gluose, whih represents a. 36% of total gluose,
beause the remaining 64%, orresponding to the β form, gives a signal at
4.65 ppm, and as suh it is strongly perturbed by the pulse sequene used
for water peak (4.68 ppm) suppression in the NMR experiments. The peak
area of latate and α-gluose was saled to the molar onentration taking
into aount that they represent the latate methyl group and the gluose
isomer, and alulated the latate/gluose molar ratio. Figure 4.18 illustrates
the latate/gluose molar ratio for eah patient sample. The analysis of vari-
ane (ANOVA with Bonferroni orretion) has been applied, and statistially
signiant dierenes were observed for the latate/gluose ratio of NT vs.
MET-CRC (p < 0.001), CIR vs. MET-CRC (p < 0.001) and HCC vs. MET-
CRC (p < 0.001).
Figure 4.18: Latate-α-gluose molar ratio for eah patient sample. Statistially signif-
iant dierenes were observed for the latate/gluose ratio of NT vs. MET-CRC (p <
0.001), CIR vs. MET-CRC (p < 0.001) and HCC vs. MET-CRC (p < 0.001). The vertial
axis has been ut to highlight the variations for NT, CIR and HCC samples, all with a ratio
<15.
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4.3 Disussion
In this study we have used high-resolution
1
H-NMR spetrosopy to investi-
gate the metabolite omposition of human hepati tissue extrats of 17 pa-
tients aeted by hepatoellular arinoma HCV-related (HCC), and 9 pa-
tients aeted by liver metastases from oloretal arinoma (MET-CRC).
As a ontrol we used irrhoti liver tissues of HCC patients (CIR) and nor-
mal liver tissue of MET-CRC patients (NT), respetively. All spetral lasses
were visualized by PCA analysis, whih also highlighted the "evolution" and
relationship of the dierent pathologial liver onditions represented by the
four NMR data lasses. The disease evolution is established along the PC1
axis (Figure 4.12A), following the inrease of the latate (Figure 4.13B), and
the remarkable derease of gluose (Figure 4.13C). The progressive inrease
of latate/gluose ratio along the PC1 axis is onsistent with the enhaned
onversion of gluose into latate, through the dierent lasses that represent
dierent tissue onditions suh as hypoxia and/or "aerobi glyolisis". Solid
malignant tumors are haraterized by pronouned tissue hypoxia [103℄ and
enhaned formation of latate [104℄, but many tumors exhibit a strong gener-
ation of latate even in the presene of oxygen. This phenomenon, known as
"aerobi glyolysis" or the "Warburg eet" [105℄, is generally onsidered the
result of onogeni alteration in gluose metabolism following malignant trans-
formation [106℄, but its signiane is still ontroversial [107℄. An elevated
latate onentration in primary lesions at rst diagnosis has been related to
an inreased risk of metastases in squamous ell arinomas of the uterine
ervix, of the head and nek, and in adenoarinomas of the retum [108℄.
Certainly no endogenous marker alone is able to predit the hypoxi status of
the tumor, and we need to nd, within hypoxi metaboli proles, a pattern
of signals (metabolites) that are expression of the pathologial hanges. How-
ever, our observations suggest that the metaboli shift towards enhaned gly-
olysis would already be present in the early stage, during multi-step hepati
tumorigenesis. Starting from liver irrhosis, widely onsidered as preanerous
lesions, the upregulation of glyolysis showed progressive rate of onversion in
dierent hepati onditions, thus indiating the metastasis group as the one,
among all lasses, requiring the larger amount of onversion in energy for its
malignany harateristis. Most probably, ell population with upregulated
glyolysis ould develop growth advantages whih promote unonstrained pro-
liferation and invasion [106℄.
The PCA analysis of variables shows that PC1 separates NT from MET-
CRC, and CIR from HCC, while PC2 separates NT from CIR, and MET-
CRC from HCC. These separations ideally identify two dierent "metaboli
developmental trajetories", whih, based on the hanges in the NMR-visible
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metabolome, desribe liver tumorigenesis (Figure 4.12). Starting from NT, it
is possible to ideally draw an ideal line through CIR to HCC, aording to a
sequel of pathologial liver alterations. Conversely, it is possible to onnet
NT diretly to MET-CRC, aording to the absene of any liver "interme-
diate" state. It is worth speulating about the possible appliations of suh
metaboli trajetories. Firstly, the trajetory ould be used to identify a
spei pathologial state by verifying when andidate metabolites deviate
from the normal path. This ould then be orrelated with known morpholog-
ial events providing insight into the progression towards HCC. Furthermore,
the trajetory ould dene the point of HCC tumorigenesis where a limited
number of genomi (DNA miroarray) and/or proteomi studies ould be ar-
ried out to better haraterize the onogeni hanges. Seondly, omparison
of metaboli trajetories an provide a suitable way to distinguish primary
tumors from metastases. Thirdly, the eets of drug treatment ould be as-
sessed by determining if the pathologial metaboli trajetory tends to the
"normal" state. On this regard, the
1
H-NMR spetra provided quantitative
data by integrating seleted metabolite signals that were found to primarily
ontribute to the lassiation of the dierent groups. In partiular, we identi-
ed the latate/gluose ratio, whih shows an opposite trend among subgroups
and within eah of them, therefore aording a reliable method for evaluating
healthy or non-healthy status of the liver.
In this study the patients who developed HCC were also aeted by hroni
irrhosis HCV-related. Hepatites C infetion is the most frequent liver infe-
tion and is onsidered a pre-anerous lesion of liver. HCV infetion is also
assoiated with an inreased risk of gluose intolerane and diabetes maybe
due to an impaired gluose homeostasis mediated diretly by HCV proteins.
Liver irrhosis is a progressive broti proess that is haraterized by the nal
nerosis of hepatoytes. In normal onditions, after arbohydrate digestion,
blood gluose level rises, and in hepatoytes insulin ats so as to stimulate
several enzymes and onvert exess gluose into glyogen, thus preventing ex-
essive osmoti pressure build up inside the ell. In fat, CIR samples (Figure
4.2B), ompared to NT samples (Figure 4.2A), show an inreased amount
of latate, and the latate/gluose ratio is a. 2 times that in NT (Figure
4.18). Hepati transformations our by sequential aumulation of geneti
and moleular alterations, and HCC is often the result of a slow and progres-
sive evolution going through the development of liver irrhosis. The latate
in HCC samples is a. 2 times higher than that in CIR samples, meaning
that there is an alteration of the arbohydrate metabolism, with enhaned
glyolysis and alteration of the triarboxyli aid (TCA) yle [15℄.
Metastasis formation is the result of a multi-step asade of events our-
ring to aner ells during tumor dissemination, whih brings about onsid-
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erable metaboli hanges [109℄. The large inrease in latate onentration as
well as the derease of intraellular gluose level was the predominant eet
for the separation of metastases from HCC and NT (Figure 4.17), and the
latate/gluose ratio in MET-CRC ranges from 9 to 40 fold higher ompared
to HCC and NT, respetively (Figure 4.18), thus suggesting a role for the
enhaned phenomenon of "aerobi glyolysis". Furthermore, the metastati
proess for remodeling and altering extra-ellular matrix, tightly assoiated
with ell proliferation, is onsistent with the elevation of latate, and has been
already reported for metastasis in axillary lymph nodes in breast aner and
human ervial aner [110℄.
The approah used in this study highlighted metaboli evolution of dier-
ent liver diseases: irrhosis, HCC, and liver metastasis. The analysis of suh
a wide range of speimen types indiated that the ommon disriminating
fator, a progressive inrease of latate onentration, is oupled with hanges
in TCA yle and alterations of the energy metabolism in the liver of CIR
and HCC patients HCV-related. In addition, the raise of latate is also ou-
pled with a stronger elevation of latate/gluose ratio of patients MET-CRC
may be due to other metaboli mehanisms. In previous HR-MAS studies
on intat tissues, the latate resonane was disarded for possible anaerobi
degradation of gluose indued during surgery or experiment [111℄. Here all
samples underwent the same treatment, and therefore we an safely exlude
external fators altering the latate levels. Furthermore, the dual extration
proedure used in our study allowed identiation and quantiation a muh
higher number of polar metabolites in omparison with protools previously
desribed for the NMR spetrosopy on intat tissues ex vivo [112℄.
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4.4 Materials and methods: b) exhaled breath
ondensate
Speimens olletion
A total of 36 paired EBC and saliva samples were olleted from the following
groups of subjets: 12 healthy subjets (HS; nine males, mean age 55.6±7.2
yrs); 12 laryngetomized patients (nine males, mean age 60.2±6.2 yrs); and 12
patients aeted by hroni obstrutive pulmonary disease (COPD; 11 males,
mean age 64.9±5.7 yrs). All HS were nonsmokers, while the laryngetomized
patients (who provided samples through a stoma, bypassing the pharynx en-
tirely) and the COPD patients were ex-smokers (at least 24 months sine
smoking). All subjets presented no oupational or other pronouned expo-
sure to organi solvents. The laryngetomized patients had been previously
treated by laryngetomy for laryngeal arinoma for at least one year prior
(range 12-18 months) and did not have a history of hroni respiratory dis-
ease or reurrent exaerbations. COPD patients had reeived diagnosis in the
past aording to the Global Initiative for Chroni Obstrutive Lung Disease
guidelines [113℄. The COPD anthropometri harateristis are summarized
in table in Figure 4.19.
Figure 4.19: Anthropometri harateristis of 12 patients aeted by hroni obstrutive
pulmonary disease. BIM: body mass index; FEV1: fored expiratory volume in one seond;
% pred: predited; FVC: Fored vital apaity; GOLD: Global Initiative for Chroni Ob-
strutive Lung Disease; M: male; F: female. FEV1, FVC and FEV1/FVC were measured
after bronhodilatation inhalation test.
None of the patients were on regular systemi or inhaled ortiosteroid treat-
ment. They were asked not to use long-ating β2-agonist and antiholinergi
agents for a period longer than 12 h and 24 h, respetively, before EBC olle-
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tion. All subjets were free from upper and/or lower airway infetion for, at
least, 4 weeks before the EBC olletion. They refrained from food intake for
4 h before the test and from aloholi drinks for 18 h before EBC olletion.
In laryngetomized patients, lower respiratory trat seretions were atively
managed by selfsutioning and leaning before eah EBC olletion.
To assess within-day repeatability, eight subjets (four HS and four COPD
patients) were asked to ollet EBC and saliva twie within the same day (at
times 0 h and 12 h). All subjets gave informed onsent and the study proto-
ol was approved by the Ethis Committee of the Monaldi Hospital (Naples,
Italy).
EBC sampling
EBC was olleted using an EoSreen ondenser (Jaeger, Wurzburg, Ger-
many) as previously desribed [40℄ (Figure 4.20). Briey, all subjets breathed
through a mouthpiee (laryngetomized patients provided samples through
the stoma) and a two-way nonrebreathing valve, whih also served as a saliva
trap, at normal frequeny and tidal volume, while sitting omfortably and
wearing a nose-lip for a period of 15 min. They maintained a dry mouth
during olletion by periodially swallowing exess saliva.
Figure 4.20: EBC shemati olleting system.
Condensate samples (3-4 ml) were immediately transferred into glass vials of
10 ml volume, losed with 20 mm butyl rubber lined with polytetrauoroethy-
lene septa, and rimped with perforated aluminium seals. Volatile substanes,
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possibly deriving from extra-pulmonary soures [114, 115, 116℄, were removed
by a gentle stream of nitrogen before sealing. Nitrogen was applied for a
variable time (1, 3, 5, 10, 15 and 20 min); no dierene was observed with
spetra aquired after 1 min nitrogen exposure, but sine suh an interval
appeared to be too short to avoid systemati errors, a 3 min interval was
hosen. Nitrogen was used beause the onentration of volatile solutes in
EBC is dependent on their distribution between the saliva, exhaled air and
droplets, and the ondensate. This distribution an be altered by multiple
fators, inluding minute ventilation, salivary pH, solubility, temperature and
sample preparation [117℄. Therefore, spetral dierenes may depend upon
unontrollable variables that prevent reliable quantiation. The nitrogen
stream also removes oxygen from solutions. Suh a proedure, used for NMR
protein struture determination [118℄, together with freezing of sealed samples
in liquid nitrogen, immediately "quenhes" metabolism at the olletion time,
and prevents any metaboli deay [37℄. Samples were then stored at -80
◦
C
until NMR analysis. Drying of the samples was avoided to irumvent irre-
versible solute preipitation and/or formation of insoluble aggregates, whih
were observed upon dissolving the dried ondensate for NMR measurements.
Pre-analytial preparation of EBC ondenser reusable
parts
Before and after olletion of eah EBC sample, the reusable parts of the
ondenser (valve, salivary trap and lamellar ondenser) were disinfeted for 15
min using a solution of a 1.5% freshly prepared hemial agent (Desogen
TM
;
FILT GmbH, Berlin, Germany), and repeatedly ushed with water following
the manufaturer's guidelines. To ompletely eliminate the disinfetant, parts
already disinfeted and washed were thoroughly rinsed for 15 min with pure
grade ethanol (96%), thereafter exhaustively soaked with deionized distilled
water for 15 min and dried under vauum at 50
◦
C.
Salivary olletion
Together with EBC olletion, a salivary sample was taken in the same day. To
avoid any interferene from exogenous agents into the oral environment, the
patients were asked to ollet all saliva available (∼ 2-4 ml), i.e. "whole" saliva
expetorated from the mouth, into a plasti universal tube immediately after
waking in the morning. As previously desribed by Silwood et al. [38℄, eah
patient was requested to refrain ompletely from oral ativities (i.e. eating,
drinking, tooth brushing, oral rinsing,smoking, et.) during the short period
between awakening and sample olletion (<5 min). Eah olletion tube
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ontained 15 µmol sodium uoride, suient to ensure that metabolites were
not generated or onsumed via the ations of bateria or baterial enzymes
present in whole saliva during periods of sample preparation and/or storage
[39℄. Speimens were transported to the laboratory on ie and immediately
entrifuged (at 20,000×g at 4 ◦C for 15 min) on their arrival to remove ells
and debris. Following this, a gentle nitrogen gas ow was applied for ∼5 min
to supernatants, whih were then stored at -80
◦
C until measurements were
made.
The
1
H-NMR proles of salivary supernatant speimens subjeted to anal-
ysis immediately after olletion into the uoride-ontaining tubes and rapid
entrifugation were ompared with those of the same samples stored as de-
sribed previously, and no dierenes were disernible, i.e. none of the riteria
investigated hanged signiantly during these periods of storage.
Sample preparation for NMR analysis
EBC samples were rapidly defrosted. To provide a eld frequeny lok, 70 µl
of a deuterium oxide (D2O) solution, ontaining 1 mM sodium 3-trimethylsilyl
(2,2,3,3-
2
H4) propionate (TSP) as a hemial shift referene for
1
H spetra and
sodium azide at 3 mM, was added to 630 µl of ondensate, thus making 700
µl total volume. Saliva samples were rapidly defrosted and 70 µl of referene
standard solution (D2O-TSP) was added to 630 µl of sample.
NMR measurements
1D spetra were reorded on a Bruker Avane spetrometer (Bruker BioSpin
GmbH, Rheinstetten, Germany) operating at a frequeny of 600.13 MHz (
1
H)
and equipped with a TCI CryoProbe
TM
(Bruker BioSpin GmbH), at a probe
temperature of 27
◦
C. The water resonane was suppressed by using the
noesypresat pulse sequene, alled noesypr1d aording to the manufatur-
ers. It has the form - RD-90
◦
-t-90
◦
-tm-ACQ, where RD is a relaxation delay,
t a short delay, 90
◦
represents a 90
◦
radio frequeny pulse, tm the mixing
time and ACQ the data aquisition period. In the present study aquisition
onditions, the arrier frequeny (O1) value was set on the water resonane,
the saturation power was 62 dB, t was 4 µs, tm was 100 ms, the spetral
amplitude was 7002.8 Hz, the time domain was 16 K, RD was 2.0 s and the
number of transients was 256. This resulted in a total aquisition time of 14
min per sample. For proessing, a line broadening of 0.6 Hz was applied and
a real spetrum size of 32 K was used. Spetra were referred to TSP, assumed
to resonate at a δ of 0.00 ppm.
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Statistial analysis
High-resolution
1
H-NMR spetra were automatially data redued to 200 inte-
gral segments ("bukets"), eah of 0.02 ppm, using the AMIX software pakage
(Bruker BioSpin GmbH). The resulting integrated regions were imported into
the SIMCA pakage (Umetris, Umea, Sweden) and used for statistial analy-
sis and pattern reognition. Before pattern reognition analysis, eah integral
region is usually normalized to the sum of all integral regions of eah spe-
trum; however, beause of the presene of ontaminant peaks, eah buket
was normalized to the TSP peak of known onentration for a referene re-
gion of between 0.014 and -0.014 ppm. The orretness of the approah was
tested by omparing the results with those obtained by referring to the sum of
all integral regions of eah ontaminant free spetrum. No signiant dier-
ene was observed between the two approahes; therefore, pattern reognition
analysis was reliable with normalization to TSP. Data were preproessed with
the Centering saling and then proessed with PCA and partial least squares
disriminant analysis (PLS-DA).
4.5 Results
Spetral dierenes between EBC and saliva
Figure 4.21 represents spetra of saliva (Fig. 4.21a, b and ) and EBC samples
(Fig. 4.21d, e and f) from one HS (Fig. 4.21a and d), one laryngetomized
patient (Fig. 4.21b and e) and one COPD patient (Fig. 4.21 and f). Saliva
spetra were highly dierent from orresponding EBC samples and were no-
tably dissimilar between patients: a visual examination establishes a orre-
spondene between spetra from a HS (Fig. 4.21a) and a laryngetomized
patient (Fig. 4.21b), but a dierene from the COPD spetrum (Fig. 4.21),
whih shows sharper lines. The most intense signals in the 0.0-3.2 ppm region
of saliva were assigned aording to previous studies [38, 101℄. Resonane
assignment was as follows: leuine δCH3s (triplet) at 0.96 ppm; propionate
βCH3 at 1.04 ppm (triplet) and αCH2 at 2.19 ppm (quartet); latate βCH3
at 1.32 ppm (doublet) and αCH at 4.11 ppm (quartet); threonine γCH3 at
1.36 ppm (doublet); alanine βCH3 at 1.47 ppm (doublet) and αCH at 4.20
ppm (quartet); aetate βCH3 (singlet) at 1.93 ppm; βCH2 of glutamate and
glutamine at 2.10 ppm (multiplet); βCH3 of pyruvate at 2.37 ppm (singlet);
α,βCH2 of suinate at 2.41 ppm (singlet); εCH2 of lysine at 3.06 (triplet);
N-CH3s of holine at 3.16 ppm and of phosphorylholine at 3.23 ppm (both
singlets); and N-CH3 of taurine at 3.23 ppm (triplet).
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Figure 4.21: Representative one-dimensional
1
H-NMR spetra of saliva (a, b and ) and
exhaled breath ondensate (EBC; d, e and f) samples from healthy (a and d), larynge-
tomized (b and e) and hroni obstrutive pulmonary disease ( and f) patients. The group
of signals entered at 3.8 ppm in saliva spetra originates from arbohydrates and is not
visible in the orresponding EBC spetra.
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Signals between 3.3 and 6.0 ppm originate from arbohydrates and were
virtually absent in the EBC spetra. Compared with saliva, EBC spetra pre-
sented fewer signals and, as observed for saliva, the COPD patient trae (Fig.
4.21f) appeared to be dierent from the HS (Fig. 4.21d) and laryngetomized
patient (Fig. 4.21e) traes. Spetral dierenes between saliva and EBC were
veried by PLS-DA analysis. Due to the omplete absene of the arbohydrate
signals in the EBC spetrum, the region 5.0 to 3.5 ppm was ut out from all
spetra, partitioning the region between 3.5 and 0.8 ppm. Figure 4.22 shows
the sore plots of saliva and EBC samples from all subjets. Considering two
PLS-DA omponents, it was possible to obtain a sample lassiation of 95%
(samples orretly lassied into dierent regions). In partiular, while EBC
samples were all lustered, the saliva samples of HS, laryngetomized and
COPD patients were positioned dierently from EBC and from eah other.
Suh a separation omes mostly from signals resonating within the 3.5-2.9 and
2.1-1.7 ppm regions. EBC and saliva samples olleted from eight subjets
twie within the same day (at times 0 h and 12 h) demonstrated good within-
day repeatability, showing no evident dierene in resonanes in the spetra.
Figure 4.22: Partial least squares disriminant analysis (PLS-DA) sores disrimination
for exhaled breath ondensate (△: laryngetomized patients; N: healthy subjets (HS); •:
hroni obstrutive pulmonary disease (COPD) patients)and saliva (: laryngetomized;
: HS; ◦: COPD). All variables were used and two PLS-DA omponents were retained in
the model, obtaining a lassiation of ∼95%. The region 5.0 to 3.5 ppm, ontaining the
arbohydrate signals, was ut out from the buketing, and only the signals between 3.5 and
0.8 ppm were analyzed. t[1℄ and t[2℄ are the rst two prinipal omponents.
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Eets of disinfetant ontamination on EBC spetra
Figure 4.23 shows the
1
H-NMR spetrum of Desogen
TM
(Fig. 4.23a) with
representative spetra of EBC samples ontaminated by the disinfetant be-
ause of insuient washing time (Fig. 4.23b and ). To ompletely eliminate
the disinfetant, parts already disinfeted and washed were thoroughly rinsed
for 15 min with pure grade ethanol (96%), thereafter exhaustively soaked with
deionized distilled water for 15 min and dried under vauum at 50
◦
C (Fig.
4.23d).
Figure 4.23: Contamination of exhaled breath ondensate (EBC) samples by Desogen
TM
(FILT GmbH, Berlin, Germany). a)
1
H-nulear magneti resonane spetrum of
Desogen
TM
, ompared with b) spetra of EBC samples after partial washing (15 min),
and ) intense water rinsing (30 min). d) Contamination was ompletely removed after
the washing proedure using ethanol. The aetate signal at 1.93 ppm was ut in all EBC
spetra. a) The vertial sale is one quarter the size of the other spetra. #: latate
resonanes.
The resonanes of the "saline" omponents of the disinfetant (itri aid,
at 2.66 ppm in the Desogen
TM
spetrum (Fig. 4.23a), and pentapotassium
bis(peroxymonosulphate) bis(sulphate), highly soluble in water) disappeared
ompletely after partial washing (15 min; Fig. 4.23b). However, minor un-
known omponents, suh as those giving signals in the 8.2-7.3 and 1.3- 0.7
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ppm regions and the signal loated at 3.2 ppm, appeared to be more persistent
even after intense water rinsing (30 min; Fig. 4.23). They were ompletely
removed only after the washing proedure using ethanol (Fig. 4.23d). As
the perturbation indued by the disinfetant ontamination of EBC samples
showed visible signals, two dierent ontaminated sets of 12 EBC samples
from all COPD patients were examined after partial washing (15 min, "high
Desogen
TM
"; Fig. 4.23b); and after intense water rinsing (30 min, "low
Desogen
TM
"; Fig. 4.23). Sine the region 8.5-7.0 ppm was absent in the
"leaned" EBC spetrum (Fig. 4.23d), as suggested by Carraro et al. [40℄,
the region 4.5 to 0.5 ppm was used and the latate signals were exluded (Fig.
4.23d). Considering two PLS-DA omponents, a lassiation of ∼72% was
obtained, with high-Desogen
TM
and low- Desogen
TM
EBC samples lassi-
ed in two wide regions (Fig. 4.24). This suggests that the presene of the
disinfetant at variable onentration aets the interpretation and the sta-
tistial analysis of the samples. However, if the presene of ontaminant is
ignored by a areful seletion of the spetral regions to be used for statistial
analysis, it is possible to orretly lassify the samples. In fat, by seleting
only the Desogen
TM
- free regions of the spetra (3.5-2.9 and 2.1-1.7 ppm),
all the samples ould be orretly lassied.
Figure 4.24: Partial least squares disriminant analysis sores disrimination for ontam-
inated exhaled breath ondensate (EBC) samples after dierent washing times; ◦: high
Desogen
TM
(15-min rinsing); •: low DesogenTM (30-min rinsing). t[1℄ and t[2℄ are the
rst two prinipal omponents.
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EBC spetral disrimination between HS, larynge-
tomized and COPD patients
The 3.5-1.7 ppm region of lean (i.e. Desogen
TM
-free) EBC samples was used
to investigate the metabolites haraterizing EBC. Figure 4.25 depits repre-
sentative spetra of HS (Fig. 4.25a), laryngetomized patients (g. 4.25b)
and COPD patients (Fig. 4.25).
Figure 4.25: Representative
1
H-nulear magneti resonane spetra of ontaminant-free
exhaled breath ondensate samples from a) healthy subjets, b) laryngetomized patients
and ) hroni obstrutive pulmonary disease patients. The aetate singlet at 1.93 ppm is
ut by a horizontal bar.
Although the region ontains few signals, the signals speially hara-
terize eah patient subset, showing both quantitative (signal intensity) and
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qualitative (signal absene/ presene) dierenes. Dierenes in intensity
were shown by the signals of: aetate βCH3 (singlet) at 1.93 ppm; propi-
onate αCH2 at 2.19 ppm (quartet); pyruvate βCH3 (singlet) at 2.37 ppm;
suinate α, βCH2 (singlet) at 2.41 ppm; glutamine γCH2 (multiplet) at 2.45
ppm; holine and phosphorylholine N-CH3s (singlets) at 3.16 and 3.23 ppm,
respetively; methanol CH3 at 3.37 ppm (singlet); and trimethylamine-N-
oxide (TMAO) N-CH3 (singlet) at 3.44 ppm, as well as by the singlet at 3.03
ppm that most likely originated from N-CH3 of reatine/reatinine. Pyru-
vate was present in the COPD spetrum (Fig. 4.25) and was very intense
in the HS spetrum (Fig. 4.25a), but barely visible in the laryngetomized
spetrum (Fig. 4.25b). Suinate was small in the HS spetrum (Fig. 4.25a),
bigger in the laryngetomized spetrum (Fig. 4.25b) but absent in the COPD
spetrum (Fig. 4.25). Glutamine was only present in the HS spetrum (Fig.
4.25a). The singlet at 3.03 ppm was only present in the COPD spetrum (Fig.
4.25). Choline and phosphorylholine were absent in the COPD spetrum
(Fig. 4.25), and TMAO was present in the HS spetrum (Fig. 4.25a), barely
seen in the laryngetomized spetrum (Fig. 4.25b) and absent in the COPD
spetrum (Fig. 4.25). All these dierenes prompted a lear disrimination
of HS, laryngetomized and COPD patients in three separate groups (Fig.
4.26).
Figure 4.26: Partial least squares disriminant analysis (PLS-DA) sores disrimination
for ontaminant-free exhaled breath ondensate samples. : healthy subjets; : laryn-
getomized patients; ◦: hroni obstrutive pulmonary disease patients. Two PLS-DA
omponents aorded a lear lassiation (∼94%), with all samples orretly lassied into
three regions. Vertial and horizontal bars refer to samples olleted in dupliate. t[1℄ and
t[2℄ are the rst two prinipal omponents.
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4.6 Disussion
The present study demonstrates, for the rst time, that NMR based metabo-
nomis an be used to analyze EBC samples from adults, allowing a lear-ut
separation between HS and patients with airway disease.
Although less sensitive than ELISA and mass spetrometry, NMR requires
minimal sample preparation with a rapid aquisition time (∼10-15 min). Fur-
thermore, it is nondestrutive and allows omplete detetion of observable
metabolites ("sample metaboli ngerprint") at a reasonable ost.
The present data show that saliva is signiantly dierent from the EBC
samples and that the presene of idential metabolites in EBC and saliva
does not hamper disrimination. By seleting the 3.5-0.8 ppm region (thereby
exluding the arbohydrate signals absent in EBC), saliva spetra learly dif-
fer from EBC (Fig. 4.22), notwithstanding the presene of some ommon
metabolites (leuine, latate, propionate, aetate, et.). EBC standardizing
guidelines [32℄ indiate that it is reasonable to assume that there is some de-
gree of oral ontamination of EBC, as saliva ontains many of the mediators
that are also present in the lower airways. Contamination of EBC is often
proved by measuring the amylase level, but suh a test is not spei and
a negative signal does not ompletely exlude minute ontribution from the
mouth. To date, there are no data omparing the metaboli saliva omposition
and a lower airway derivate suh as EBC, mainly beause ondensate samples
have been sreened for single, spei biomarkers and not as a whole. Indeed,
ombined saliva and EBC analysis by a metabonomis method has been re-
ently advoated [116℄. In light of these assumptions, the urrent authors also
examined EBC from laryngetomized patients, whih may represent a true
saliva-free material from the lower airways, showing that in those subjets all
saliva spetra stritly diered from orresponding EBC samples. Importantly,
all EBC and saliva olleted twie within the same day (12 h apart) showed
good within-day repeatability (Fig. 4.26). Taken together, the data suggest
that saliva ontamination may play a minor role in the interpretation of EBC
by NMR-based metabonomis. The inuene of external ontaminants was
also onsidered, as the International Consensus on EBC reommends speial
are in the disinfetion of reusable parts of ondensers [31℄. Upon standard
leaning, all EBC spetra presented signals orresponding to unknown inative
substanes of the disinfetant. They persisted even after strong and repeated
water soaking, and the presene of variable disinfetant onentration upon
dierent leaning levels may render lassiation less eetive. Complete re-
moval of the disinfetant signals was observed after washing the reusable parts
with 96% ethanol and then rinsing thoroughly with distilled water for 15 min.
EBC samples were "spiked" by partially washing the apparatus with water,
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after treatment with freshly prepared Desogen
TM
, obtaining dierent degrees
of EBC ontamination. Sine the itri aid signals were absent after partial
washing (Fig. 4.23b), it is important to underline that the potentially toxi
saline omponents of the disinfetant are easily removed from the ondenser
apparatus by water washing. However, the removal of interfering residual
external ontaminants is ruial for a orret EBC analysis. There are no
data on the inuene of residual disinfetant agents of reusable parts of EBC
ondensers. The inuene of residual Desogen
TM
on reported biomarker lev-
els was not evaluated by an ELISA method, but the present authors suggest
that the potential role of external ontamination on the variability of some
biomarkers [119, 120℄ should be evaluated. Signiantly, by seleting spei
regions of EBC spetra for statistial analysis, an eient disrimination of
samples was obtained. Although separation between HS and COPD patients
an be ahieved by either fored expiratory volume in one seond measure-
ments or linially, the urrent authors evaluated the apability of NMR-based
metabonomis to separate EBC subjets with airway diseases (COPD) from
subjets without respiratory diseases. Five NMR signals appear to dierenti-
ate "respiratory" (COPD) from "non-respiratory" (HS and laryngetomized)
subjets. As a omparison, Carraro et al. [40℄ reported the single aetate
signal variation as distintive in asthmati hildren with respet to ontrols.
They hypothesized that aetate inrease might be related to inreased aety-
lation of pro-inammatory proteins in the extraellular spae in the airway
environment. Furthermore, they found that peaks in 3.2- 3.4 ppm regions
of the NMR spetrum of asthmati hildren were probably related to oxi-
dised ompounds. Heili-Frades et al. [121℄ have reported preliminary data
on signiant variations between NMR EBC spetra of normal and patholog-
ial ases with impliations for orrelative studies using spetral and linial
lassiation.
In the present study, by omparing EBC from respiratory (COPD) pa-
tients and non-respiratory (HS and laryngetomized) subjets, as well as a-
etate, four additional signal variations were found, whih are likely to have
inluded the methoxy ompounds. It an be speulated that suh variations
ould derive from the inreased oxidative stress that is a hallmark of COPD,
and these variations are usually investigated in EBC by measuring a limited
number of markers [119, 120℄. Also, the omparison between HS, larynge-
tomized and COPD EBC samples showed a lear-ut dierene (Fig. 4.25)
in the COPD patients ompared with the other subjets. Figure 4.26 depits
a signiant statistial dierene along t[1℄ of COPD patients ompared with
HS and laryngetomized patients, who are less separated along t[2℄. This
ould be interpreted by the fat that laryngetomized patients were not la-
beled as COPD before or after surgery; furthermore, mild airow limitation
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was deteted in only a few subjets (data not shown).
In onlusion, NMR-based metabonomis an safely be applied to exhaled
breath ondensate in adults, allowing an unambiguous denition irrespetive
of natural and/or artiial ontaminants. In partiular, the urrent authors
report that nulear magneti resonane spetra of exhaled breath ondensate,
olleted with a devie using a salivary trap, do not show the presene of saliva
signals. Furthermore, for the disinfetant medium urrently used, a areful
seletion of the nulear magneti resonane region allows a lear statistial
lassiation of samples, even for ontaminated exhaled breath ondensate
samples. Finally, the present results suggest that ondensate an be eiently
studied as a whole, and that nulear magneti resonane may beome a leading
diagnosti tehnique in this eld.
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This hapter is based on the paper: R. Romano, D. Paris, F. Aernese,
F. Barone, A. Motta. Frational volume integration in two-dimensional NMR
spetra: CAKE, a Monte Carlo approah. J Magn Res 192 (2008) 294-301.
5.1 Simulation tests
In order to test the CAKE algorithm, we simulated peaks of dierent shape
and overlapping degree. First, we applied CAKE to simulated overlapping
peaks of known volume with dierent overlapping degrees to optimize the
number NPbase to determine the frational volume VF with the Hit-or-Miss
method. Seond, we tested CAKE integration on dierent ellipti NMR peak
setions.
5.1.1 Simulations: bias vs. overlapping
We onsidered two Gaussian peaks entered at (xi, yi), of equation
G(x, y) = Aiexp[−
(x− xi)2 + (y − yi)2
2σ2i
] (5.1)
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volume Vi = 2piσ
2
iAi and with half-height width ζi =
√
2σ2i ln2, i = 1, 2, and
addition of Gaussian noise. Denoting by
d =
√
(x1 − x2)2 + (y1 − y2)2 (5.2)
the distane between the peak enters, it is possible to dene the parameter η
η ≡ ζ1 + ζ2
d
(5.3)
as an index of the overlap, suh that a large value orresponds to strong
overlap. Setting the amplitude A1 = 50.0 and the dispersion 2σ
2
1 = 2.0 to
obtain V1 = 100pi, the A2 and 2σ
2
2 values were hanged so as to keep the
volume V2 onstant (V2 = 100pi), with the overlap index being 0.8 ≤ η ≤ 1.5.
The ontour plots of the simulated peaks are reported in Figure 5.1and Figure
5.2 for η = 0.8 (peak 1), and η = 1.5 (peak 2).
Figure 5.1: 3D Gaussian peaks with dierent degree of overlap (η): a) η = 0.8 and b)
η = 1.5.
CAKE integration was ompared with the standard one, obtained by sum-
ming the amplitudes of all data points within a polygonal bounding the peak.
In order to establish the best number of extrations NP in the Hit-or-Miss de-
termination of R, and the best number of extrations NPbase in the Hit-or-Miss
determination of the frational volume, simulations were onduted in the ex-
treme limit of η = 1.5.(Figure 5.2, peak 2). Figure 5.3 reports the perentage
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Figure 5.2: Contour plot of two Gaussian peaks with dierent degree of overlap (η): peak
1, η = 0.8 and peak 2, η = 1.5. For the denition of η see text. d is the distane between
peak enters.
Figure 5.3: Perentage (%) of Bias as a funtion of the number of extrations (NP ) to
estimate the R fator. For eah NP we tested several NPbase values to estimate the volume
fration, and they are indiated with orresponding symbols on the right.
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of Bias vs. the number of extrations NP , for dierent NPbase values ranging
from 100 to 1000 (right olumn in Figure 5.3). As it an be seen, results be-
ome unbiased for NP ≥ 1500, while, exept for NPbase = 100 (square symbol),
the dependene on NPbase is negligible. Aordingly, the values NP = 2000,
and NPbase = 500 appear to be a good ompromise between omputing time
and auray. The results of the simulations are reported as perentage of
Bias vs. the degree of overlap for a signal-to-noise ratio (SNR) of 34.9±3.0
(Figure 5.4A) and 56.1±4.7 (Figure 5.4B). The standard integration (lled
squares) was arried out by bounding the peak with an ellipse, while for the
CAKE integration (lled irles) we used NP = 2000, and NPbase = 500. In
both ases, eah integration was repeated 10 times.
Figure 5.4: Simulation results expressed as perentage of Bias in volume estimation vs.
the degree of overlap (η). Integration was ahieved with the standard () and the CAKE
(•) methods at dierent signal-to-noise ratios. (A) SNR = 34.9±3.0; (B) SNR = 56.1±4.7.
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In Figure 5.4A (SNR = 34.9±3.0), the standard method gives unbiased
integration values only for low overlap index η ≤ 0.9. (Figure 5.2, peak 1), to
beome totally biased for η ≥ 1.0. In ontrast, CAKE always performs better,
espeially in the range 1.0 ≤ η ≤ 1.3, whih represents dierent degree of over-
lap ommonly found in 2D spetra. Overall, the frational method appears to
be unbiased in the whole 0.8 ≤ η ≤ 1.5 range, that is for strongly overlapping
peaks and in the presene of a low signal-to-noise ratio (SNR = 34.9±3.0).
Figure 5.4B reports the same simulations with a SNR = 56.1±4.7. The stan-
dard method performs well for η ≤ 0.9, with a general trend very similar to
that observed for lower SNR (Figure 5.4A). In ontrast, the frational method
shows a general redution of the bias perentage, with values generally lower
than those obtained in the previous simulation. Taken together our results
suggest that, regardless of the SNR, the CAKE method performs always better
than the standard one.
5.1.2 Simulations: bias vs. eentriiy
Sine experimental 2D-peak shapes are lose to ellipti, we tested CAKE on
a simulated ellipse of known volume. In partiular, we onsidered peaks of
equation
Si(ω1, ω2) = Ai(
2pi
σ1iσ2i
) exp (−∆ω
2
1
2σ21i
) exp (−∆ω
2
2
2σ22i
) (5.4)
volume Vi = Ai and ontour of eentriity
ei =
√
1− min(σ1i, σ2i)
max(σ1i, σ2i)
(5.5)
with addition of Gaussian noise. Integration was arried out in two ways. The
frational area was rstly seleted randomly (i.e. avoiding any symmetry),
and, seondly, symmetrially with respet to any of the semiaxes of the ellipti
peak. The random hoise (Figure 5.5A) produed a sattered bias distribution
between 0 and 20% for 0.8 ≤ e ≤ 0.74, with a maximum of 25% for e = 0.78.
For 0.8 ≤ e ≤ 0.9, whih orresponds to a ratio between semiaxes in the
range of 0.45 ≤ b/a ≤ 0.60, the average bias is 5%. This result appears to
be relevant as the b/a value orresponds to the experimental ellipti shapes
usually found in 2D spetra.
The symmetry seletion of the frational area (Figure 5.5B) shows a bias
≤10% for all eentriity values, with the maximum at e = 0.78 redued to
12%. For 0.8 ≤ e ≤ 0.9 the average bias is very similar to that found for the
random seletion (Figure 5.5A).
In onlusion, it is suggested that, for elliptial peaks, sliing should be done
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symmetrially with respet to one of the semiaxes, even though for 0.8 ≤
e ≤ 0.9, that is for most of the experimental 2D peaks, the bias is essentially
indipendent from the seletion.
Figure 5.5: CAKE integration of simulated ellipti peaks expressed as perentage of Bias
in volume estimation vs. Contour eentriity (e). In (A) the frational area was hosen
in a non symmetri way with respet to the semimajor and the semiminor axes of the
ellipti peak. In (B) the frational area was hosen in a symmetri way with respet to the
semimajor and semiminor axes of the ellipti peak. In both ases the SNR = 69.5±3.2.
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5.2 Experimental test
To test the eay of the new integration method, after simulations, CAKE
was applied to 2D-NMR spetra of a sample ontaining two tripeptides in
known onentrations; we ompared peak volume estimations obtained by
CAKE with those obtained by standard integrations.
5.2.1 NMR data olletion
The sample, a mixture of the tripeptides Ala-Phe-Ala (AFA) and pyroGlu-His-
Pro (thyrotropin-releasing hormone, TRH), was prepared by dissolving appro-
priate amounts in 0.5 ml of
1H2O/
2H2O (90/10 v/v) to yield for eah peptide
a onentration of 0.10 mM.
1H−NMR spetra, reorded at 295 K and pH
7.4, were aquired on a Bruker DRX-600 spetrometer operating at 600 MHz,
equipped with a TCI ryoprobe
TM
tted with a gradient along the Z-axis.
Spetra were referened to sodium 3-(trimethylsilyl)-[2,2,3,3-
2H4℄propionate.
Homonulear 2D lean TOCSY spetra [122℄ were reorded by standard teh-
niques and inorporating the exitation sulpting sequene [95℄ for water sup-
pression. We used a pulsed-eld gradient double eho with a soft square pulse
of 4 ms at the water resonane frequeny, with the gradient pulses of 1 ms eah.
512 equally spaed evolution time-period t1 values were aquired, averaging 4
transients of 2048 points, with 6024 Hz of spetral width. Time-domain data
matries were all zero-lled to 4096 in both dimensions, yielding a digital res-
olution of 2.94 Hz/pt. Prior to Fourier transformation, time-domain ltering
was applied with a Lorentz-Gauss window to both t1 and t2 dimensions. The
TOCSY experiment was reorded with a spin-lok period of 64 ms, ahieved
with the MLEV-17 pulse sequene [98℄.
5.2.2 Software
NMR data proessing and baseline orretion were obtained with the program
XWINNMR (Bruker, Biospin GmbH, Ettlingen, 2003). Standard peak inte-
gration was arried out with the programs XWINNMR and MestRe-C [123℄,
in whih integrated volumes are omputed as the sum of all digital intensities
within a retangular box and a tunable ellipse bounding a peak, respetively.
CAKE software was written in MATLAB language and was implemented in
the graphial environment of MATLAB 7.1.
80 Chapter 5. CAKE simulations and experimental tests
5.2.3 Experimental Results
The power of the CAKE approah was tested on a TOCSY spetrum of a
mixture of two tripeptides, AFA and TRH (Figure 5.6).
Figure 5.6: (a)TOCSY spetrum of the AFA and THR tripeptides aliphati region, a-
quired at 300K with 64 msec mixing time. Expansions (b) and () report peaks originating
from γCH2 protons of the TRH pyroGlu [labeled 1 in (b)℄, and α and β protons of AFA
Phe2 [labeled 2 in ()℄, and TRH His2 [labeled 3 in ()℄.
In order to have an internal referene we seleted pairs of peaks, eah of
them stemming from a single spin system, suh that they have similar inten-
sity within eah pair but one peak overlaps with others. In partiular we hose
pairs that exemplify the orrelations between the γCH2 (labeled 1 in Figure
5.6b), and between α and β protons of AFA Phe2 (labeled 2 in Figure 5.6a),
and TRH His2 labeled 3 in Figure 5.6a). The magnitude of a given TOCSY
peak [governed by mixing oeients alk(τm) for transfer of magnetization
through the spin system from spin Il to spin Ik℄ depends on the topology of
the spin system, the oupling onstants between pairs of spins, the eieny
of the isotropi mixing sequene employed, and the relaxation rate during the
mixing pulse. Although the robustness of the integration method does not de-
pend upon the experiment type or the intensity of the hosen peak, we looked
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for pairs in whih the peaks are expeted to have similar intensity but one
of them overlaps with others. Aordingly, we seleted the AMX spin system
of the two aromati residues (Figure 5.6a) in AFA and TRH. From relax-
ation measurements (not shown) at two dierent spetrometer frequenies,
we estimated for both peptides similar orrelation times and relaxation rates;
furthermore, the measured
3Jαβ and
3Jαβ′ values in eah spin system were
idential, therefore exluding dierenes in the peak intensity due to dierent
oupling onstants; nally, the single
2Jγγ′ value for the γCH2 protons of the
TRHpyroGlu warrants a similar intensity for the two peaks within eah pair.
The seleted peaks were integrated with standard and with CAKE meth-
ods and the results are reported in Figure 5.6 as the Dierene perentage of
volume for eah ross-peak pair. For the CAKE integration we seleted the
most internal level belonging to a single peak, whih had elliptial symmetry
with eentriity e > 0.75. The values obtained with CAKE for the three
peak pairs are all within 10%, giving an unbiased estimation of the dierene
perentage of the volumes in eah pair. In ontrast, the standard method
estimates for eah peak pair values > 35% for pairs 1 and 2, and ≈ 25% for
pair 3. Surprisingly, the CAKE approah gives for the pair 1, whih lies on
the TOCSY diagonal, about zero volume dierene, supporting robustness for
the method, also in the presene of elliptial symmetry.
5.2.4 Bias vs. digital resolution
The dependene of CAKE on digital resolution was investigated by integrating
the peak pair 2 (Fig. 5.6) at dierent digital resolution (0.5, 1.1, 2.2, 4.3 and
8.6 Hz/pt), and integration was arried out for eah value with standard and
CAKE methods (Fig. 5.7). The volume of pair 2 overlapping peak (loated
at ω1 =4.75 ppm and ω2 =3:05 ppm, Fig. 5.6) was ompared to the volume
of the orresponding single peak at ω1 =4.75 ppm and ω2 =3:05 ppm at its
maximum digital resolution, taken as referene. The values obtained with
CAKE are all within 2%, giving an unbiased estimation of the % Dierene
up to 8.6 Hz/pt. On the ontrary, the standard method estimates values
>10% already at 2.2 Hz/pt to beome ≈ 25% at 8.6 Hz/pt. This nding
an be explained by onsidering that a low resolution drastially redues the
number of points within an area identied by the i -th level, whih, in turn, is
itself poorly dened. Therefore, the sum of points done by standard methods
is obviously biased. On the ontrary, the Hit-or-Miss tehnique used in CAKE
does not sum the existing points inluded in a level bound area, but generates
random points and ounts the number of "hits" (or points) that are inluded
in the unknown area. Sine a ubi interpolation (see Chapter 2) is used as a
deisional mean to establish if the extrated point an be onsidered a "hit",
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a low digital resolution ould, in priniple, aet the peak prole. However,
with CAKE we were able to orretly integrate peaks with digital resolution
up to a. 30 Hz/pt.
Figure 5.7: Dierene perentage (%) of volume determination at dierent resolution for
ross-peak 2, as labeled in Fig.5.6. The digital resolution was a. 0.5, 1.1, 2.2, 4.3 and 8.6
Hz/pt. Filled squares and irles refer to the standard and CAKE integration methods,
respetively.
5.3 Disussion
Quantiation of NMR spetra is fundamental both in metabolomis/
metabonomis and in the struture determination of biomoleules. However,
quantiation of peaks is often hampered by the degeneray of the NMR res-
onane frequeny, a fator that aggravates with the inreasing size of maro-
moleules and the number of metabolites. Here we have presented the CAKE
approah that uses the symmetry of a single in-phase peak (a peak with a
unique enter orresponding to its maximum) to alulate its volume. It is ob-
tained by multiplying the frational volume by the R fator, a proportionality
ratio between the total and the frational volume, both evaluated with Monte
Carlo tehniques. Therefore, the peak volume an be estimated by integrating
a known fration of the peak, and the frational volume an be hosen so as
to minimize the eet of overlap in omplex NMR spetra. Stritly speaking
CAKE applies to Gaussian peaks showing ylindrial or ellipti symmetry.
However, an NMR spetrum is losely approximated by Lorentzian funtions,
whih in its 2D shape show the so-alled "star eet". It an be easily removed
by 2D Lorentz-to-Gauss transformation, whih is routinely used for in-phase
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experiments, like TOCSY and NOESY. Therefore, the major assumption in
this study is that the Lorentzian signal is onverted into a Gaussian line by a
Lorentz-to-Gauss transformation, whih is routinely applied in 2D data ma-
nipulation. Integration of simulated and experimental 2D in-phase peaks with
dierent degree of overlap shows that CAKE works well even for strongly over-
lapping peaks. The main advantage of CAKE is its simpliity as diulties
in its use are omparable to those presented by methods that sum all data
points in a dened area. In fat, the user only has to selet a peak slie not
overlapping with other peaks therefore avoiding the guess of the total ontour
shape of the peak. Furthermore, CAKE does not require any time-onsuming
tting of the peaks to funtional forms, and therefore it an be easily inorpo-
rated as a subroutine in any NMR proessing software. Tests on tripeptides
have shown that CAKE is a powerful method for volume integration. The
substantial independene of CAKE on digital resolution and SNR warrants
that it an be safely used for peak integration in three-dimensional spetra.
Beause of its inherent simpliity the software an be extended to automated
integration of three- and possibly higher-dimensionality NMR spetra.
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This hapter is based on the paper: A. Motta, D. Paris, G. Andreotti, D.
Melk. Monitoring real-time metabolism of living ells by fast two-dimensional
NMR spetrosopy. Submitted to Analitial Chemistry.
6.1 Materials and methods
6.1.1 Cell ulturing
Axeni ultures of T. rotula ells were prepared as desribed in Miralto and o-
workers protools [124℄. Briey, diatoms were grown in Guillard's (F/2) Ma-
rine Enrihment Basal Salt Mixture Powder medium, ontaining standard and
dierent salinities (20, 35 and 45 %0) and unlabeled or
15
N-labeled NaNO3,
on a 12 h light/12 h dark yle, and a light intensity of 20.9 J mol
−1 µm−2s−1.
Cells were kept in a 10 L arboy for 1 week and then harvested in the early
stationary phase by entrifugation at 1200g in a swing-out rotor. Prior to ex-
tration, diatom ultures were allowed to settle overnight and the supernatant
was gently removed by sution with a water pump.
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6.1.2 Extrats manipulation
Combined extration of polar and lipophili metabolites from unlabeled and
15
N-labeled diatoms ells was arried out by using the methanol/hloroform
proedure [92℄ Pelleted ells were resuspended in methanol (4 ml/g pellet)-
water (0.85 ml/g pellet), and soniated for 2 min. Then 4 ml/g pellet of
hloroform were added and the homogenate was gently stirred and mixed on
ie for 10 min using an orbital shaker (the solution must be mono-phasi).
Other 4 ml/g pellet of hloroform and 4 ml/g pellet of water were then added,
and the nal mixture was shaken well and entrifuged at 12000g for 15 min at
4
◦
C. This proedure separates a water/methanol phase at the top (aqueous
phase, with the polar metabolites), a phase of denatured proteins and ellular
debris in the middle, and a hloroform phase at the bottom (lipid phase,
with lipophili ompounds). The upper layer of eah sample was transferred
into glass vials, and, after solvent removal under a stream of dry nitrogen,
was stored at -80
◦
C until required. For 1D and 2D NMR experiments the
polar extrats were resuspended in 700 µl H2O-D2O (90%-10%), and then
transferred into an NMR tube.
6.1.3 Gel eletrophoresis for protein detetion
To eventually exlude the detetions of small proteins from the SOFAST-
HMQC in vivo spetra aquisition of T. rotula, we performed SDS-PAGE
eletrophoresis. SDS-PAGE on slab gel ontaining 12 and 15% arylamide, in
order to reah the lower limit of 3 kDa, was performed by using the standard
proedure (12). Proteins were loated on the gels using Comassie Brillant Blue
staining. For 12% arylamide we used Phosphorylase b (97.4 kDa), bovine
serum albumine (66.2 kDa), ovalbumin (45.0 kDa), arboni anhydrase (31.0
kDa), trypsin inhibitor (21.5, kDa), and lysozyme (14.4 kDa), all from BIO-
RAD. For 15% arylamide we used hymotrypsinogen A (24 kDa), ytohrome
 (13 kDa), bovine panreati tripsin inhibitor (BPTI, 6.6 kDa), insulin B-
hain (3.5 kDa), all from Sigma. Size-exlusion hromatography was arried
out at room temperature, using a 1.5× 50 m Sephadex G-50 Fine olumn and
a ow rate of 0.2 ml/min. Separate hromatography experiments of standard
amino aids were performed in 50 mM sodium phosphate, at pH 6.7, using
a 55 µM peptide onentration. Salmon alitonin (3.4 kDa), baitrain (1.4
kDa), standard amino aids all from Sigma, and sodium 3-(trimethylsilyl)-
(2,2,3,3-
2
H4)propionate (TSP, 172 Da), from Aldrih, were used as moleular
mass standards.
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6.1.4 NMR experiments
All NMR experiments were arried out on a Bruker DRX-600 spetrometer,
equipped with a TCI CryoProbe
TM
tted with a gradient along the Z-axis.
T. rotula
1
H and TOCSY spetra
1
H-NMR spetra were reorded at 600 MHz and were referened to internal
TSP. Clean total orrelation spetrosopy (TOCSY)[97℄ spetra of ells and
extrats were reorded by using the time-proportional phase inrementation
of the rst pulse, and inorporating the exitation sulpting sequene [95℄ for
water suppression. We used a double-pulsed eld gradient eho, with a soft
square pulse of 4 ms at the water resonane frequeny, with the gradient pulses
of 1 ms eah in duration. In general, 256 equally spaed evolution-time period
t1 values were aquired, averaging 2 (for diatoms) and 8 (for extrats) tran-
sients of 2048 points, with 6024 Hz of spetral width. Time-domain data ma-
tries were all zero-lled to 4K in both dimensions, applying, prior to Fourier
transformation, a Lorentz-Gauss window with dierent parameters for both
t1 and t2 dimensions in all the experiments.
T. rotula
1
H-
15
N SO-FAST-HMQC parameters set-up
The
1
H-
15
N SOFAST-HMQC pulse sequene follows the sheme proposed by
Shanda and o-workers [2℄ (Figure 6.1). First,
1
H pulses are applied band-
seletively [77℄; seond, the rst
1
H pulse has an adjustable ip angle α that
allows further optimization of the sensitivity of the experiment for a hosen
(short) san time [78℄. In pratie, the ip angle is hosen to ensure that part
of the proton magnetization is restored along the z-axis by the following 180
◦
pulse; third, the small number of radio-frequeny pulses redues signal loss
due to pulse imperfetions and B1 eld inhomogeneities, and limits the eets
of sample and probe heating. We used polyhromati PC9 pulse shape for
adjustable ip-angle band-seletive exitation [125℄ whih yields quite uniform
exitation over the desired bandwidth for ip angles in the range 0
◦
< α <
130
◦
. As a refousing pulse on the
1
H hannel we tested the r-SNOB [82℄ and
RE-BURP [83℄ proles. Beause of a signal inrease of a. 35%, we used RE-
BURP instead of r-SNOB, onrming the nding of Shanda et al. for proteins
[3℄. The aquisition parameters were as follows: α=120◦, ∆(1/2JHX) = 6.7-
5.4 ms, δ= 1.8 ms, tmax1 =20 ms, t
max
2 =40 ms, and trel=1 ms. Forty omplex
data points were aquired in the t1 dimension, adding 4 dummy sans (n =
80 + 4). The band-seletive
1
H exitation (PC9, 3.0 ms) and refousing (RE-
BURP, 2.03 ms) pulses were entered at 8.0 ppm overing 4.0 ppm.
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Figure 6.1: SOFAST-HMQC experiment to reord
1H-X (X=15N or 13C) orrelation
spetra of proteins. Filled and open pulse symbols indiate 90
◦
and 180
◦
rf pulses, exept for
the rst
1H exitation pulse applied with ip angle α. As desribed in the next setion, the
variable ip-angle pulse has a polyhromati PC9 shape, and band-seletive
1H refousing
is realized using an r-SNOB prole. The transfer delay ∆ is set to 1/(2JHX), the delay
δ aounts for spin evolution during the PC9 pulse, and trec is the reyle delay between
sans.
15
N was deoupled with GARP-4 [126℄, with a 90
◦
pulse length of 600 µs. 15N
hemial shifts are relative to external
15
NH4NO3 (5 M in 2 M HNO3).
6.2 Results
In the ell, metabolites experiene a visosity of a. 2-3 times that of water
[127, 128℄ and interat with other omponents. As suh, restrition of the ro-
tational freedom may be predited [127℄. However, their low moleular weight
is likely to ounterbalane the visosity eet, and an inrease of the average
eetive T1 of in-ell metabolites an be expeted. Therefore, a balane of
intrinsi and extrinsi properties will aet metabolite relaxation. We rstly
heked if high visosity is a prerequisite for appliation of SOFAST-HMQC
to low-moleular weight metabolites by using a sample of
15
N-labeled Leu (5
mM, pH 1.4, 300 K) in the presene of SDS, with a visosity of 9 relative to
water (0.894 P). The results of the appliation of the SOFAST pulse sequene
to suh a sample are reported in Figure 6.2A, in whih a
1
H-
15
N orrelation
peak, entered at 8.01 and 172 ppm, is observed.
The inuene of the visosity on the volume of the ross-peak in Figure 6.2A
was investigated by lowering the SDS onentration, and therefore the rela-
tive visosity from 9 to 1 (no SDS). In the 9-3 range we observed that the
ross-peak volume remained onstant, to signiantly derease upon a redu-
tion of the relative visosity from 3 to 1 (Figure 6.2B). We estimated that
in the absene of SDS (relative visosity of 1) the ross-peak volume halves.
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Figure 6.2: (A)
1
H-
15
N SOFAST-HMQC spetrum of
15
N-labeled Leu (5 mM, pH 1.4,
300 K) in the presene of SDS, with an aquisition time of 14 s. The ∆(1/2JHX) value
was set to 6.7 ms sine JHX = 74.6 Hz; for the remaining aquisition parameters see the
Materials and Methods Setion. (B) Dependene of the ross-peak volume on the visosity
of the medium, relative to water.
Therefore, for a moleule as small as Leu (MW 132.17 Da), a visosity of
a. 3 times that of water, orresponding to the visosity inside a living ell
[127℄, maximizes the intensity of the
1
H-
15
N SOFAST-HMQC peak. However,
the eient
1
H-
15
N dipolar interation is also important, sine a well-dened
ross peak, although with an intensity 1/2 of the maximum, is observed in
the experiment without SDS.
6.2.1 T. rotula
1
H and TOCSY spetra
Due to intraellular visosity, a moleule in a ellular environment displays
broad NMR line widths as a onsequene of the redued tumbling rate, and
overlapped, poor quality spetra are the likely result. In our ase, a further
ompliation omes from the presene of high salt onentration in the sea
water ulture medium, used to suspend the ells in the NMR tube. The nal
result is that the 1D spetrum obtained for a
15
N-labeled T. rotula sample
ontaining a. 50-million ells will show an unresolved "bumpy" distribution
of the resonanes, as shown in Figure 6.3.
In order to better resolve signals from T. rotula, we aquired
1
H (Figure
6.4) and TOCSY spetra (Figure 6.5) of T. rotula polar extrats (see Materials
and Methods Setion).
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Figure 6.3:
1
H spetrum of in vivo
15
N-labeled T.rotula (50×106 ells).
Figure 6.4:
1
H spetrum of
15
N-labeled T.rotula polar extrats (400×106 ells).
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Figure 6.5: TOCSY spetrum of
15
N-labeled T.rotula polar extrats (400×106 ells).
6.2.2 T. rotula
1
H-
15
N SOFAST-HMQC spetra
The
1
H-
15
N SOFAST-HMQC orrelation spetrum of a 50-million T. rotula
ells is reported in Figure 6.6: it was diretly aquired in the ulture medium
in an overall experimental time of 12 s.
Figure 6.6:
1
H-
15
N orrelation spetrum (entral part) of a sample of 50-million
15
N-
labeled diatom ells (in sea water ulture medium, 300 K) reorded in 12 s. 1D traes
orrespond to the proton spetrum (top), and (left) to a olumn extrated along the
15
N
dimension at the
1
H frequeny indiated by the dashed vertial line in the 2D spetrum.
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In suh a short aquisition time, the NMR experiment ertainly does not kill
the ells, and in fat the number of olony-forming units/OD is the same
before and after the 12-s SOFAST-HMQC experiment (data not shown). Fur-
thermore, ompared with 1D, the 2D experiment presents a higher S/N, as
it an be appreiated from the trae on the left side of Figure 6.6, extrated
along the
15
N dimension (vertial broken line in Figure 6.6).
The robustness of in-ell SOFAST NMR spetrosopy was investigated by
ontrolling several aspets [86℄. Firstly, beause of the high S/N ratio, we
redued the number of ells from 50 millions down to 10 millions, whih, as
shown in all the experiments below, appear to be suient for fast aquisition
and high S/N spetra. Figure 6.7A reports the
1
H-
15
N SOFAST-HMQC spe-
trum of a 10-million ells sample of
15
N-labeled T. rotula, taken diretly in the
ulture medium. It reprodues the spetral pattern of the more onentrated
sample of Figure 6.6, and shows a high S/N ratio with well resolved reso-
nanes. Seondly, when dealing with living ells it is important to onsider
that moleules outside the ell tumble faster and, therefore, exhibit sharper
lines than internal metabolites in a more visous environment. Consequently,
a small fration of extraellular moleules ould ontribute disproportionately
to, or even dominate, the spetrum. This was investigated after removal of
the ells from the sample by entrifugation and ltration, and analyzing the
supernatant. It ontained no detetable extraellular metabolites as its or-
responding SOFAST-HSQC spetrum, aquired with the same parameters as
the in-vivo spetrum 6.7A, showed no signals (Figure 6.7B), therefore ruling
out any interferene from the extraellular metabolites in Figure 6.7A. This
was onrmed by the following step. The pellet separated from the super-
natant was resuspended in fresh standard ulture medium giving a spetrum
(Figure 6.7C) idential to that observed when in vivo (spetrum 6.7A). It is
onluded that the ross-peaks we observed in the SOFAST-HSQC experi-
ments of Figures 6.6 and 6.7A stem from moleules within the ell, and that
the amount of the released moleules, if present, are beyond detetion.
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Figure 6.7:
1
H-
15
N SOFAST-HMQC spetrum of
15
N-labeled T. rotula in varying ondi-
tions: (A) in vivo spetrum of 10-million ells diretly in the ulture medium aquired in
12 s; (B) supernatant of the sample used in (A) after removal of all ells by entrifugation
and ltration (vertial sale × 8); (C) pellet after resuspension in fresh ulture medium;
(D) polar extrat obtained with the methanol/hloroform protool to remove proteins (see
text). Peaks are labeled with the single-letter ode for amino aids; the asterisk marks a
yet unidentied peak.
6.2.3 Gel eletrophoresis results
When investigating intraellular
15
N-labeled metabolites in vivo by NMR, are
must be taken to avoid detetion of resonanes originating from low-moleular
weight proteins within the ell, whih might beome labeled beause of the un-
spei labeling proess. This was examined by analyzing the polar extrats
of the diatom ells by using the methanol/hloroform protool. The used pro-
edure separates the polar metabolites in the water/methanol phase at the
top, a phase of denatured proteins and ellular debris in the middle, and a
hloroform phase at the bottom, with lipophili ompounds [92℄. As a proof to
rule out the presene of signals originating from polypeptides/proteins in the
above SOFAST-HSQC spetra, we arried out SDS-PAGE gels of the polar
extrats obtained from 10- and 50-million ells. Figure 6.8 reports a 12%-
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arylamide gel (6.8A), and a 15% arylamide gel (6.8B). In both, the absene
of bands in lanes 1 and 2 (reporting 10-million ell extrat ran in dupliate)
and lanes 3 and 4 (50-million ell extrat ran in dupliate) onrmed the total
absene of polypeptides/proteins down to a moleular weight of 3 kDa.
Figure 6.8: SDS polyarylamide gel eletrophoresis of
15
N-labeled T. rotula polar extrats:
(A) 12% arylamide, and (B) 15% arylamide. In both, Lane S reports prestained protein
standards with moleular weight indiated on the left side; lanes 1 and 2, 10-million ells
ran in dupliate; lanes 3 and 4, 50-million ells ran in dupliate. Comassie Brillant Blue
staining was used to visualize proteins.
For lower moleular weight we resorted to size-exlusion hromatography un-
der the experimental onditions used for NMR analysis. At pH 6.7, all the
moleules present in the polar extrat eluted with an apparent moleular mass
omparable to that of TSP (172 Da). The experiments desribed above on-
rm that the ross-peaks we observed are assoiated with metabolites within
the ells, and that the presene of polypeptides/proteins in the spetra an
be safely exluded. The SOFAST-HMQC spetrum of the polar extrat (Fig-
ure 6.7D) well ompares with the in vivo (6.7A) and the resuspended pellet
(6.7C) data, showing only small dierenes in hemial shift, possibly reet-
ing dierenes in salt omposition of the in-vitro NMR buer and the yto-
plasm. Identiation of the ross-peaks was ahieved upon a areful titration
of the solution with standard amino aids, and the signals are labeled with
the one-letter ode in spetra 6.7A and 6.7D. It is important to notie that
the spetral position of free amino aids orresponds to that observed within
the ell, and a similar behavior is observed for proteins inside and outside the
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ell [86℄. However, as for proteins, the great advantage of the observation of
in-ell metabolites by fast NMR spetrosopy does not lie in the strutural
investigation, but on the possibility to examine the behavior of metabolites
diretly in the ellular ompartments, and follow their fate upon a hange of
the physiologial state of the ell as well as in the possible interation with
unlabeled/labeled proteins.
6.3 Disussion
Our simple appliation had shown that 2D
1
H-
15
N orrelation spetra of
15
N-
labeled metabolites an be reorded in living ells in only 10-15 s of data
aquisition using the SOFAST-HMQC sequene that provides high sensitiv-
ity. To the best of our knowledge, this is the rst time that high-quality 2D
orrelation spetra of metabolites have been diretly reorded in living ells
on a time sale of seonds of experimental time and high S/N. Obviously,
these are preliminary results and more experimental investigations are needed
to explore the potentiality of SOFAST experiments for metaboli detetion
purpose sine, in the future, it is desirable to extend the investigation to eu-
karyoti ell systems. Potential appliations inlude in-ell investigation under
physiologial or stressing onditions, high-throughput haraterization of ell
lines by NMR, testing potential drugs by fast measures of in-ell metaboli
hanges, as well as investigation of the primary nitrogen metabolism in plant
ells.
Conlusions
The results here presented onrm that high resolution NMR spetrosopy is
partiularly suited for biomarkers disovery. We applied reent NMR avanes
and developed new tools in order to improve analysis of biologial samples for
biomarkers haraterization in metabolomi strategies.
Appliation of NMR spetrosopy, oupled with pattern reognition meth-
ods, to two biologial issues is reported: a) the progressive liver alterations
during tumorigenesis and b) the exhaled breath ondensate of patients with
airway diseases.
In our rst appliation, we investigated the metabolite omposition of
human hepati tissue extrats of 17 patients aeted by hepatoellular ari-
noma HCV-related (HCC), and 9 patients aeted by liver metastases from
oloretal arinoma (MET-CRC); as a ontrol, we used irrhoti liver tissues
of HCC patients (CIR) and normal liver tissue of MET-CRC patients (NT),
respetively. PCA, together with OPLS-DA analysis, allowed spetral lasses
lustering and lassiation. All spetra were visualized by sores and loadings
plots, whih also highlighted the "evolution" and relationship of the dierent
pathologial liver onditions represented by the four NMR data lasses. The
disease evolution learly followed the inrease of the latate together with the
remarkable derease of the gluose signal, thus suggesting that suh a signal
pattern may at as a potential marker for assessing pathologial hepati le-
sions. In partiular, we identied a statistial model that ould be used to
distinguish hepati metastasis and human hepatoarinoma from a "normal"
(healthy) hepati tissue. The progressive inrease of latate/gluose ratio,
within the hepati tissues, is onsistent with the enhaned onversion of glu-
ose into latate, through the dierent lasses that represent dierent tissue
onditions suh as hypoxia and/or "aerobi glyolisis". Although this trend
is generally known, as onsidered the result of onogeni alteration in gluose
metabolism following malignant transformation, we reported a further infor-
mation whih is the extreme latate/gluose onversion showed by MET-CRC,
ompared with all of the others tissue samples under investigation. Indeed,
metastasis formation is the result of a multi-step asade of events ourring
to aner ells during tumor dissemination, whih brings about onsiderable
metaboli hanges. The large inrease in latate onentration as well as the
derease of intraellular gluose level was the predominant eet for the sep-
aration of metastases from HCC and NT, and the latate/gluose ratio in
MET-CRC ranges from 9 to 40 fold higher ompared to HCC and NT, re-
spetively, thus suggesting a role for the enhaned phenomenon of "aerobi
glyolysis".
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A further appliation was addressed to investigate the
1
H-NMR metabolite
prole of exhaled breath ondensate (EBC) of patients with dierent airway
diseases. EBC, obtained by ooling exhaled air from spontaneous breath-
ing, is a simple, noninvasive and useful tool to study the biohemial and
inammatory moleules in the airway lining uid. Thirtysix paired EBC and
saliva samples, obtained from healthy subjets, laryngetomized patients and
hroni obstrutive pulmonary disease (COPD) patients, were analyzed ap-
plying
1
H-NMR spetrosopy followed by prinipal omponent analysis. Our
aim was to assess the role of pre-analytial variables (saliva and disinfetant
ontamination), potentially inuening EBC, to evaluate the stability and re-
produibility of samples and to disriminate healthy subjets from patients
with airway disease. The results show that saliva metaboli prole is sig-
niantly dierent from the EBC samples and that the presene of idential
metabolites in EBC and saliva does not hamper disrimination. Exluding the
arbohydrate signals (absent in EBC), saliva spetra learly dier from EBC,
notwithstanding the presene of some ommon metabolites (leuine, latate,
propionate, aetate, et.). Furthermore, by examining EBC from larynge-
tomized patients, whih may represent a true saliva-free material from the
lower airways, we found that in those subjets all saliva spetra stritly diered
from orresponding EBC samples. Importantly, all EBC and saliva olleted
twie within the same day (12 h apart) showed good within-day repeatability.
Finally, we ould state that saliva ontamination may play a minor role in
the interpretation of EBC by NMR-based metabonomis. Furthermore, we
onsidered the inuene of external ontaminants, as the International Con-
sensus on EBC reommends speial are in the disinfetion of reusable parts of
ondensers. Upon standard leaning, all EBC spetra presented signals orre-
sponding to unknown inative substanes of the disinfetant, that ompletely
disappeared only after washing the reusable parts with 96% ethanol. Af-
terwards, by seleting spei non-ontaminated regions of EBC spetra for
statistial analysis, an eient disrimination of EBC subjets with airway
diseases (COPD) from subjets without respiratory diseases, was obtained.
Some NMR signals appear to dierentiate "respiratory" (COPD) from "non-
respiratory" (HS and laryngetomized) subjets, by showing both quantitative
(signal intensity) and qualitative (signal absene/presene) dierenes; among
all pyruvate, suinate, glutamine, TMAO, holine and phosphorylholine.
As a further enhaned tool for high thoughput NMR analysis, we devel-
oped a new integration method for 2D NMR spetra quantiation, whih
is fundamental both in metabonomis and in the struture determination of
biomoleules. Quantitative information from multidimensional NMR exper-
iments an be obtained by peak volume integration. However, the standard
proedure of seleting a region around the hosen peak and addition of all
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values is often biased by poor peak denition and/or the degeneray of the
NMR resonane frequeny, a fator that aggravates with the inreasing size
of maromoleules and the number of metabolites. In this thesis, we devel-
oped and tested a simple method, alled CAKE, for volume integration of
moderately-to-strongly overlapping peaks, using the Monte Carlo Hit-or-Miss
tehniques, relying upon the peak line shapes in two-dimensional NMR. The
CAKE approah uses the symmetry of a single in-phase peak (a peak with
a unique enter orresponding to its maximum) to alulate its volume. It
is obtained by multiplying the frational volume by the R fator, a propor-
tionality ratio between the total and the frational volume, both evaluated
with Monte Carlo tehniques. Therefore, the peak volume an be estimated
by integrating a known fration of the peak, and the frational volume an be
hosen so as to minimize the eet of overlap in omplex NMR spetra. All
integration of simulated and experimental 2D in-phase peaks, with dierent
degree of overlap, showed the CAKE eay in estimating umbiased peak
volume, even for strongly overlapping peaks. Moreover, it is substantially
independent on digital resolution and SNR.
Finally, we suessfully investigated the possibility of exploiting enhaned
NMR pulse sequenes for fast spetra aquisition. In partiular, we applied
the so-alled SOFAST-HMQC pulse sheme to detet in-ell metabolism. Cre-
ated and designed for protein observation, the pulse sequene is based upon
very short experimental reyle delays, whih, of ourse, rely on short T1 re-
laxations time. Even if metabolites are often haraterized by T1 relaxations
time longer than those of proteins, we have applied the SOFAST experiment
to
15
N-labeled Thalassiosira rotula diatom ells obtaining, to the best of our
knowledge, the rst appliation of fast NMR spetrosopy. We olleted spe-
tra in 10-15 s of aquisition time, pinpointing the T. rotula
1
H-
15
N metaboli
proling diretly in living ells. Our results, denitively show that the ap-
pliation of SOFAST experiments provides an instantaneous piture of the
metaboli pathways ourring in a well-dened physiologial state, therefore
avoiding the observation of an "average" metabolism obtainable with aqui-
sition time of hours. With this approah, biohemial proesses, taking plae
during metaboli modiations, an be followed by real-time multidimensional
NMR methods, where spetral hanges are monitored during a very short tem-
poral period. In the past, the long aquisition times assoiated with 2D NMR
have limited the appliation of real-time 2D NMR to slow kineti proesses
with harateristi time onstants of minutes to hours. The introdution of
fast 2D data aquisition shemes, suh as the SOFAST experiments, ould ex-
tend the time window aessible to real-time 2D NMR to the range of seonds,
thus representing a further advantaging tool for metabonomi and biomarkers
investigations. Obviously, it would be extremely advantageous to extend the
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desribed investigations to eukaryoti ell systems, where potential applia-
tions inlude in-ell investigation under physiologial or stressing onditions,
indued by external toxiants or potential drugs, NMR metaboli harateri-
zation of ell lines, as well as investigation of the metabolism in plant ells. In
general, extensive appliation in the elds of metabolomis and metabonomis
an be predited, and many of the above appliations are in progress in our
laboratory.
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